• HPO Home
  •      Uberpheno (Cross-species phenotype data)     
  •      Phenomizer             
  • Feedback
  •        
  • Map







Name      Synonyms
Seizures      Epilepsy
Seizure


Primary ID      Alternative IDs
HP:0001250      HP:0001275 HP:0001303 HP:0002125 HP:0002182 HP:0002279 HP:0002306 HP:0002348 HP:0002391 HP:0002417 HP:0002430 HP:0002431 HP:0002432 HP:0002434 HP:0002437 HP:0002466 HP:0002479 HP:0002794 HP:0006997 HP:0010520


Term definition
Seizures are an intermittent `abnormality of the central nervous system` (FMA:HP:0002011) due to a sudden, excessive, disorderly discharge of cerebral neurons and characterized clinically by some combination of disturbance of sensation, loss of consciousness, impairment of psychic function, or convulsive movements. The term epilepsy is used to describe chronic, recurrent seizures.


Super-classes (vis)      Sub-classes (vis)
Abnormality of the central nervous system      Generalized seizures ; Dialeptic seizures ; Focal seizures ; Febrile seizures ; Status epilepticus ; Symptomatic seizures ; Epileptic spasms

PURL-link
http://purl.obolibrary.org/obo/HP_0001250


Diseases / genes associated with this term

Disease      Gene(s)
WOLF-HIRSCHHORN SYNDROME     
1P36 MICRODELETION SYNDROME     
ANGELMAN SYNDROME (TYPE 1)     
XQ28 (MECP2) DUPLICATION     
2Q33.1 DELETION SYNDROME     
ANGELMAN SYNDROME (TYPE 2)     
15Q13.3 MICRODELETION SYNDROME     
ADAMS-OLIVER SYNDROME      ARHGAP31
ACROMEGALOID FACIAL APPEARANCE SYNDROME     
ADENYLOSUCCINASE DEFICIENCY      ADSL
ADIPOSIS DOLOROSA     
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE      GNAS
ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY     
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1      ATP1A2
#105210 AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED;;HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED;;TRANSTHYRETIN AMYLOIDOSIS;;AMYLOID POLYNEUROPATHY, FAMILIAL; FAPAMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED, INCLUDED;;AMYLOID CARDIOMYOPATHY, TRANSTHYRETIN-RELATED, INCLUDED      TTR
ANGELMAN SYNDROME      CDKL5 ; MECP2 ; UBE3A
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED     
APNEA, OBSTRUCTIVE SLEEP     
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS     
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA     
BEHCET SYNDROME     
#113620 BRANCHIOOCULOFACIAL SYNDROME; BOFS;;BOF SYNDROME;;BRANCHIAL CLEFTS WITH CHARACTERISTIC FACIES, GROWTH RETARDATION, IMPERFORATENASOLACRIMAL DUCT, AND PREMATURE AGING;;HEMANGIOMATOUS BRANCHIAL CLEFTS-LIP PSEUDOCLEFT SYNDROME;;LIP PSEUDOCLEFT-HEMANGIOMATOUS BRANCHIAL CYST SYNDROME      TFAP2A
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET     
#115150 CARDIOFACIOCUTANEOUS SYNDROME;;CFC SYNDROME;;CFCS      MAP2K1 ; MAP2K2 ; KRAS ; BRAF
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED      KRIT1
CENTRALOPATHIC EPILEPSY     
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5Q35 DELETION SYNDROME      NSD1
CHOREOATHETOSIS, FAMILIAL INVERTED     
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED      SATB2 ; UBB
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS     
#120330 PAPILLORENAL SYNDROME;;RENAL-COLOBOMA SYNDROME;;OPTIC NERVE COLOBOMA WITH RENAL DISEASE;;COLOBOMA OF OPTIC NERVE WITH RENAL DISEASE;;OPTIC COLOBOMA, VESICOURETERAL REFLUX, AND RENAL ANOMALIES;;RENAL-COLOBOMA SYNDROME WITH MACULAR ABNORMALITIESRENAL HYPOPLASIA, ISOLATED, INCLUDED      PAX2
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED      KCNQ2
#121201 SEIZURES, BENIGN FAMILIAL NEONATAL, 2; BFNS2;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, 2; BFNC2      KCNQ3
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE; 1      FEB1
COPPER DEFICIENCY, FAMILIAL BENIGN     
#122470 CORNELIA DE LANGE SYNDROME 1; CDLS1;;CDLS;;CDL;;TYPUS DEGENERATIVUS AMSTELODAMENSIS;;DE LANGE SYNDROME;;BRACHMANN-DE LANGE SYNDROME; BDLS      NIPBL
CORTICOTROPIN-RELEASING HORMONE      CRH
#123500 CROUZON SYNDROME;;CRANIOFACIAL DYSOSTOSIS, TYPE I; CFD1;;CROUZON CRANIOFACIAL DYSOSTOSIS      FGFR2
#124000 MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1; MC3DN1      BCS1L
#124200 DARIER-WHITE DISEASE; DAR;;KERATOSIS FOLLICULARIS;;DARIER DISEASE; DDDARIER DISEASE, ACRAL HEMORRHAGIC TYPE, INCLUDED;;DARIER DISEASE, SEGMENTAL, INCLUDED      ATP2A2
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL      NOTCH3
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA      ATN1
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL      AQP2
KENNY-CAFFEY SYNDROME, TYPE 2     
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10      DYT10 ; PRRT2
EDINBURGH MALFORMATION SYNDROME     
EPILEPSY, BENIGN OCCIPITAL     
EPILEPSY, READING     
COCKAYNE SYNDROME, TYPE B      ERCC6
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA      ACVR1
#135400 HYPERTRICHOSIS TERMINALIS, GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA;;FIBROMATOSIS, GINGIVAL, WITH HYPERTRICHOSIS;;CHROMOSOME 17Q24.2-Q24.3 DELETION SYNDROME;;MICRODELETION 17Q24.2-Q24.3 SYNDROME     
%135500 ZIMMERMANN-LABAND SYNDROME; ZLS;;LABAND SYNDROME;;FIBROMATOSIS, GINGIVAL, WITH ABNORMAL FINGERS, FINGERNAILS, NOSE ANDEARS, AND SPLENOMEGALY     
#135900 COFFIN-SIRIS SYNDROME; CSS;;FIFTH DIGIT SYNDROME     
FLYNN-AIRD SYNDROME     
#136570 CHROMOSOME 16P12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16P12, INCLUDED      FRA16A
GIANT PIGMENTED HAIRY NEVUS     
GROWTH-MENTAL DEFICIENCY SYNDROME OF MYHRE      SMAD4
%141300 HEMIFACIAL ATROPHY, PROGRESSIVE; HFA;;PARRY-ROMBERG SYNDROME     
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED      CACNA1A
#141750 ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED;;ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, DELETION-TYPE;;ATR-16 SYNDROME;;ATR, DELETION-TYPE;;HEMOGLOBIN H-RELATED MENTAL RETARDATION; HBHR;;MENTAL RETARDATION WITH HEMOGLOBIN H;;CHROMOSOME 16P DELETION SYNDROME     
HYPOPARATHYROIDISM, FAMILIAL ISOLATED      GCM2 ; PTH ; CASR
#146255 HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE; HDR;;HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME;HDRS;;BARAKAT SYNDROME;;NEPHROSIS, NERVE DEAFNESS, AND HYPOPARATHYROIDISM      GATA3
#146510 PALLISTER-HALL SYNDROME; PHS;;HYPOTHALAMIC HAMARTOBLASTOMA, HYPOPITUITARISM, IMPERFORATE ANUS, ANDPOSTAXIAL POLYDACTYLY      GLI3
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR FUSED INCISORS SINGLE UPPER CENTRAL INCISOR SINGLE CENTRAL MAXILLARY INCISOR SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR SYNDROME, INCLUDED SMMCI SYNDROME, INCLUDED      SHH
JACOBSEN SYNDROME      JBS
#147920 KABUKI SYNDROME 1; KABUK1;;KABUKI SYNDROME;;KABUKI MAKE-UP SYNDROME; KMS;;NIIKAWA-KUROKI SYNDROME      KMT2D
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME     
HYPEREKPLEXIA, HEREDITARY      GLRA1
SYSTEMIC LUPUS ERYTHEMATOSUS      TREX1
#152950 MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTALRETARDATION; MCLMR;;MICROCEPHALY, LYMPHEDEMA, CHORIORETINAL DYSPLASIA SYNDROME;;MLCRD SYNDROME;;MICROCEPHALY AND CHORIORETINOPATHY WITH OR WITHOUT MENTAL RETARDATION,AUTOSOMAL DOMINANT;;CDMMR SYNDROME;;LYMPHEDEMA, MICROCEPHALY, CHORIORETINOPATHY SYNDROME;;LYMPHEDEMA AND RETINAL FOLDS WITH MICROCEPHALY AND MICROPHTHALMOS      KIF11
#153480 BANNAYAN-RILEY-RUVALCABA SYNDROME; BRRS;;BANNAYAN-ZONANA SYNDROME; BZS;;RILEY-SMITH SYNDROME;;RUVALCABA-MYHRE-SMITH SYNDROME; RMSS;;MACROCEPHALY, PSEUDOPAPILLEDEMA, AND MULTIPLE HEMANGIOMATA;;MACROCEPHALY, MULTIPLE LIPOMAS, AND HEMANGIOMATA      PTEN
#154020 HYPOMAGNESEMIA 2, RENAL; HOMG2;;MAGNESIUM WASTING, RENAL;;MAGNESIUM LOSS, ISOLATED RENAL      FXYD2
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2Q23.1 DELETION SYNDROME, INCLUDED      MBD5
#157170 HOLOPROSENCEPHALY 2; HPE2      SIX3
#158170 CHROMOSOME 9P DELETION SYNDROME;;MONOSOMY 9P SYNDROME     
#158350 COWDEN DISEASE; CD;;COWDEN SYNDROME; CS;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED      PTEN
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED      FSHMD1A
MYOCLONIC EPILEPSY, HARTUNG TYPE     
MYOCLONUS AND ATAXIA     
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS     
MYOCLONUS, HEREDITARY, WITH PROGRESSIVE DISTAL MUSCULAR ATROPHY      ASAH1
#160120 EPISODIC ATAXIA, TYPE 1; EA1;;EPISODIC ATAXIA WITH MYOKYMIA; EAM;;ATAXIA, EPISODIC, WITH MYOKYMIA; AEM; AEMK;;PAROXYSMAL ATAXIA WITH NEUROMYOTONIA, HEREDITARY;;MYOKYMIA WITH PERIODIC ATAXIAMYOKYMIA 1, INCLUDED;;CONTINUOUS MUSCLE FIBER ACTIVITY, HEREDITARY, INCLUDED;;ISAACS-MERTENS SYNDROME, INCLUDED;;MYOKYMIA 1 WITH OR WITHOUT HYPOMAGNESEMIA, INCLUDED      KCNA1
#162200 NEUROFIBROMATOSIS, TYPE I; NF1;;NEUROFIBROMATOSIS, PERIPHERAL TYPE;;VON RECKLINGHAUSEN DISEASE      NF1
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT      DNAJC5
NEVI FLAMMEI, FAMILIAL MULTIPLE     
#163200 SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM;;SFM SYNDROME;;LINEAR SEBACEOUS NEVUS SYNDROME;;SEBACEOUS NEVUS SYNDROME, LINEAR;;JADASSOHN NEVUS PHAKOMATOSIS; JNP;;NEVUS SEBACEUS OF JADASSOHN;;ORGANOID NEVUS PHAKOMATOSIS;;EPIDERMAL NEVUS SYNDROME, FORMERLY      HRAS ; KRAS
OCULOCEREBROCUTANEOUS SYNDROME     
PARIETAL FORAMINA      MSX2
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME     
PELGER-HUET ANOMALY      LBR
+170993 PEROXISOME BIOGENESIS FACTOR 2; PEX2;;PEROXISOMAL MEMBRANE PROTEIN 3; PXMP3;;PEROXISOMAL MEMBRANE PROTEIN, 35-KD; PMP35;;PEROXISOMAL ASSEMBLY FACTOR 1; PAF1;;PEROXIN 2ZELLWEGER SYNDROME 3, INCLUDED; ZWS3, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 5, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 10, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP F, INCLUDED      PEX2
*170995 ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 3; ABCD3;;PEROXISOMAL MEMBRANE PROTEIN 1; PXMP1;;PEROXISOMAL MEMBRANE PROTEIN, 70-KD; PMP70      ABCD3
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME     
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME     
#175700 GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS;;POLYSYNDACTYLY WITH PECULIAR SKULL SHAPE      GLI3
PORENCEPHALY, FAMILIAL      COL4A1
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED      HMBS
#176270 PRADER-WILLI SYNDROME; PWS;;PRADER-LABHART-WILLI SYNDROMEPRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED;;PRADER-WILLI-LIKE SYNDROME ASSOCIATED WITH CHROMOSOME 6, INCLUDED      SNRPN ; NDN
#176920 PROTEUS SYNDROME;;GIGANTISM, PARTIAL, OF HANDS AND FEET, NEVI, HEMIHYPERTROPHY, ANDMACROCEPHALYELATTOPROTEUS SYNDROME, INCLUDED      AKT1
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME     
#179613 RECOMBINANT CHROMOSOME 8 SYNDROME;;REC8 SYNDROME;;CHROMOSOME 8Q22.1-QTER DUPLICATION AND 8PTER-P23.1 DELETION;;SAN LUIS VALLEY SYNDROME     
#180849 RUBINSTEIN-TAYBI SYNDROME 1; RSTS1;;RUBINSTEIN SYNDROME;;BROAD THUMBS AND GREAT TOES, CHARACTERISTIC FACIES, AND MENTAL RETARDATION;;BROAD THUMB-HALLUX SYNDROME      CREBBP
180870 RUVALCABA SYNDROME     
SCHOLTE SYNDROME     
%181750 SCLERODERMA, FAMILIAL PROGRESSIVE;;SYSTEMIC SCLEROSIS, SUSCEPTIBILITY TOCREST SYNDROME, INCLUDED     
#182230 SEPTOOPTIC DYSPLASIA;;DE MORSIER SYNDROMEPITUITARY HORMONE DEFICIENCY, COMBINED, 5, INCLUDED; CPHD5, INCLUDED;;GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES, INCLUDED      HESX1
#182290 SMITH-MAGENIS SYNDROME; SMS;;CHROMOSOME 17P11.2 DELETION SYNDROMESMITH-MAGENIS CHROMOSOME REGION, INCLUDED; SMCR, INCLUDED      RAI1
SNEDDON SYNDROME     
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR     
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA     
STURGE-WEBER SYNDROME     
SUPRABULBAR PARESIS, CONGENITAL     
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER      ENG
THANATOPHORIC DYSPLASIA, TYPE I      FGFR3
#188400 DIGEORGE SYNDROME; DGS;;CHROMOSOME 22Q11.2 DELETION SYNDROME;;HYPOPLASIA OF THYMUS AND PARATHYROIDS;;THIRD AND FOURTH PHARYNGEAL POUCH SYNDROMEDIGEORGE SYNDROME CHROMOSOME REGION, INCLUDED; DGCR, INCLUDED;;TAKAO VCF SYNDROME, INCLUDED;;CATCH22, INCLUDED      DGCR ; TBX1
PREECLAMPSIA/ECLAMPSIA 1      PEE1
#191100 TUBEROUS SCLEROSIS 1; TSC1;;TUBEROUS SCLEROSIS COMPLEX; TSC;;TUBEROSE SCLEROSIS; TS      TSC1
#192315 VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL;;CEREBRORETINAL VASCULOPATHY, HEREDITARY; CRV;;RETINOPATHY, VASCULAR, WITH CEREBRAL AND RENAL INVOLVEMENT AND RAYNAUDAND MIGRAINE PHENOMENA      TREX1
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT      FGF23
WATSON SYNDROME      NF1
#193700 ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A;;FREEMAN-SHELDON SYNDROME; FSS;;WHISTLING FACE-WINDMILL VANE HAND SYNDROME;;CRANIOCARPOTARSAL DYSTROPHY;;CRANIOCARPOTARSAL DYSPLASIA      MYH3
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4P16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME      WHCR
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION     
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS      VPS13A
#200990 ACROCALLOSAL SYNDROME; ACLS;;HALLUX DUPLICATION, POSTAXIAL POLYDACTYLY, AND ABSENCE OF CORPUS CALLOSUM;;SCHINZEL ACROCALLOSAL SYNDROMEJOUBERT SYNDROME 12, INCLUDED; JBTS12, INCLUDED;;JOUBERT SYNDROME 12/15, DIGENIC, INCLUDED      KIF7 ; ACLS
#201450 ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD;;ACADM DEFICIENCY;;MCAD DEFICIENCY;;MCADH DEFICIENCY;;CARNITINE DEFICIENCY SECONDARY TO MEDIUM-CHAIN ACYL-COA DEHYDROGENASEDEFICIENCY      ACADM
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF      ACADS
GLUCOCORTICOID DEFICIENCY 1      MC2R
ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM      PEX5
ALEXANDER DISEASE      GFAP
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME     
#203700 MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A;;ALPERS DIFFUSE DEGENERATION OF CEREBRAL GRAY MATTER WITH HEPATIC CIRRHOSIS;;ALPERS PROGRESSIVE INFANTILE POLIODYSTROPHY;;ALPERS SYNDROME;;ALPERS-HUTTENLOCHER SYNDROME;;NEURONAL DEGENERATION OF CHILDHOOD WITH LIVER DISEASE, PROGRESSIVE;PNDC      POLG
#203800 ALSTROM SYNDROME; ALMS;;ALSS      ALMS1
CEROID LIPOFUSCINOSIS, NEURONAL, 3      CLN3
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE      CLN6
CEROID LIPOFUSCINOSIS, NEURONAL, 2      TPP1
%206570 ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT;;DIVRY-VAN BOGAERT SYNDROME     
TAKAYASU ARTERITIS     
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY      ARG1
ARGININOSUCCINIC ACIDURIA      ASL
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE     
#208400 ASPARTYLGLUCOSAMINURIA; AGU;;GLYCOSYLASPARAGINASE DEFICIENCY;;ASPARTYLGLUCOSAMINIDASE DEFICIENCY;;AGA DEFICIENCY;;GLYCOASPARAGINASE;;ASPARTYLGLYCOSAMINURIA      AGA
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA     
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED      ATM
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE     
AUTISM     
#209880 CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS;;AUTONOMIC CONTROL, CONGENITAL FAILURE OF ONDINE CURSE, CONGENITALONDINE-HIRSCHSPRUNG DISEASE, INCLUDED; OHD, INCLUDED;;CCHS WITH HIRSCHSPRUNG DISEASE, INCLUDED;;HADDAD SYNDROME, INCLUDED      BDNF ; RET ; ASCL1 ; PHOX2B ; EDN3 ; GDNF
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION     
#210200 3-@METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY;;MCCD TYPE 1;;MCC1 DEFICIENCY;;3-@METHYLCROTONYLGLYCINURIA I;;METHYLCROTONYLGLYCINURIA TYPE I      MCCC1
SECKEL SYNDROME 1      ATR
#210710 MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I; MOPD1;;MOPD I; MOPD;;OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I;;BRACHYMELIC PRIMORDIAL DWARFISM;;TAYBI-LINDER SYNDROME; TALS;;CEPHALOSKELETAL DYSPLASIA;;LOW-BIRTH-WEIGHT DWARFISM WITH SKELETAL DYSPLASIA      RNU4ATAC
#210720 MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2;;MOPD II;;OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II      PCNT
BIRD-HEADED DWARFISM WITH PROGRESSIVE ATAXIA, INSULIN-RESISTANT DIABETES,GOITER, AND PRIMARY GONADAL INSUFFICIENCY     
BOWEN-CONRADI SYNDROME      EMG1
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY     
#211750 C SYNDROME;;OPITZ TRIGONOCEPHALY SYNDROME;;TRIGONOCEPHALY SYNDROME      CD96
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I     
#212065 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A;;CDG IA; CDGIA;;JAEKEN SYNDROME;;PHOSPHOMANNOMUTASE 2 DEFICIENCY;;CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE IA, FORMERLY      PMM2
#212066 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A;;CDG IIA; CDGIIA;;ALKURAYA SYNDROME;;MENTAL RETARDATION, GROWTH RETARDATION, PROMINENT COLUMELLA, AND OPENMOUTH;;CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE II, FORMERLY; CDGS2,FORMERLY      MGAT2
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X     
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY      SLC25A20
CARNOSINEMIA     
#212750 CELIAC DISEASE; CD;;CELIAC SPRUE;;GLUTEN-SENSITIVE ENTEROPATHY; GSECELIAC DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; CELIAC1, INCLUDED     
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME     
CEREBELLOPARENCHYMAL DISORDER II     
CEREBROTENDINOUS XANTHOMATOSIS      CYP27A1
#214100 ZELLWEGER SYNDROME; ZS;;CEREBROHEPATORENAL SYNDROME;;CHR SYNDROME;;ZWS      PEX1
CEREBROHEPATORENAL SYNDROME, VARIANT TYPES      PEX5
#214150 CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1;;COFS SYNDROME; COFS;;PENA-SHOKEIR SYNDROME, TYPE II      ERCC6
GRISCELLI SYNDROME, TYPE 1      MYO5A
CHEDIAK-HIGASHI SYNDROME      LYST
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1      PEX7
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION     
#215700 CITRULLINEMIA, CLASSIC;;CITRULLINEMIA, TYPE I; CTLN1;;CITRULLINURIA;;ARGININOSUCCINATE SYNTHETASE DEFICIENCY;;ASS DEFICIENCY      ASS1
#216360 COACH SYNDROME;;CEREBELLAR VERMIS HYPO/APLASIA, OLIGOPHRENIA, CONGENITAL ATAXIA, OCULARCOLOBOMA, AND HEPATIC FIBROSIS;;JOUBERT SYNDROME WITH CONGENITAL HEPATIC FIBROSIS      TMEM67 ; RPGRIP1L ; CC2D2A
COCKAYNE SYNDROME, TYPE A      ERCC8
#216550 COHEN SYNDROME; COH1;;HYPOTONIA, OBESITY, AND PROMINENT INCISORS;;PEPPER SYNDROME;;CHS1, FORMERLY      VPS13B
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET     
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE     
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC     
AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY      SLC12A6
#218340 TEMTAMY SYNDROME; TEMTYS;;MENTAL RETARDATION WITH OR WITHOUT CRANIOFACIAL DYSMORPHISM, OCULARCOLOBOMA, OR ABNORMAL CORPUS CALLOSUM      C12ORF57
218350 CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE;;BILATERAL LAMBDOID AND SAGITTAL SYNOSTOSIS; BLSS     
CRANIOSYNOSTOSIS WITH FIBULAR APLASIA     
BALLER-GEROLD SYNDROME      RECQL4
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME     
CRIGLER-NAJJAR SYNDROME      UGT1A1
CROME SYNDROME     
#219150 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA; ARCL3A;;DE BARSY SYNDROME A;;CUTIS LAXA, CORNEAL CLOUDING, AND MENTAL RETARDATION;;PROGEROID SYNDROME OF DE BARSY      ALDH18A1
#219200 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A;;ARCL2;;CUTIS LAXA WITH CONGENITAL DISORDER OF GLYCOSYLATION;;CUTIS LAXA WITH GROWTH AND DEVELOPMENTAL DELAY;;CUTIS LAXA, DEBRE TYPE;;CUTIS LAXA WITH BONE DYSTROPHY;;CUTIS LAXA WITH JOINT LAXITY AND RETARDED DEVELOPMENT      ATP6V0A2
CUTIS MARMORATA TELANGIECTATICA CONGENITA     
MITOCHONDRIAL COMPLEX IV DEFICIENCY      COX6B1 ; COX14 ; FASTKD2 ; COA5
#220111 LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC;;CYTOCHROME C OXIDASE DEFICIENCY, FRENCH CANADIAN TYPE;;COX DEFICIENCY, FRENCH CANADIAN TYPE;;COX DEFICIENCY, SAGUENAY-LAC-SAINT-JEAN TYPE;;LEIGH SYNDROME, SAGUENAY-LAC-SAINT-JEAN TYPE      LRPPRC
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY      GLYCTK
220219 DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA,AND BRACHYTELEPHALANGY     
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY     
%220500 DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, AND MENTAL RETARDATIONSYNDROME;;DOOR SYNDROME;;DIGITORENOCEREBRAL SYNDROME;;DRC SYNDROME;;BRACHYDACTYLY DUE TO ABSENCE OF DISTAL PHALANGES;;ERONEN SYNDROME     
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY      TREM2 ; TYROBP
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD      WFS1
DIAMINOPENTANURIA     
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA      LRP2
DIHYDROPYRIMIDINASE      DPYS
DIGITORENOCEREBRAL SYNDROME     
DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL      DBH
%223370 DUBOWITZ SYNDROME     
#223900 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3;;HSAN III;;DYSAUTONOMIA, FAMILIAL; DYS; FD;;RILEY-DAY SYNDROME      IKBKAP
#224050 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME1; CAMRQ1;;CEREBELLAR HYPOPLASIA, VLDLR-ASSOCIATED;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 1;;CEREBELLAR ATAXIA, CONGENITAL, AND MENTAL RETARDATION, AUTOSOMAL RECESSIVE;;DYSEQUILIBRIUM SYNDROME; DES      VLDLR
224250 DYSMYELINATION WITH JAUNDICE     
%224300 DYSOSTEOSCLEROSIS     
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME      PVRL1
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED      TREX1
#225753 PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4;;ENCEPHALOPATHY, FATAL INFANTILE, WITH OLIVOPONTOCEREBELLAR HYPOPLASIA      TSEN54
ENDOCARDIAL FIBROELASTOSIS     
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME      ROGDI
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION     
CELIAC DISEASE, EPILEPSY AND CEREBRAL CALCIFICATION SYNDROME     
EPILEPSY-TELANGIECTASIA     
#226980 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS;;MED-IDDM SYNDROME;;IDDM-MED SYNDROME;;WOLCOTT-RALLISON SYNDROME      EIF2AK3
FATTY METAMORPHOSIS OF VISCERA     
#229050 FOLATE MALABSORPTION, HEREDITARY      SLC46A1
FOUNTAIN SYNDROME     
FRUCTOSE AND GALACTOSE INTOLERANCE     
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY      ALDOB
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY      FBP1
FRYNS SYNDROME     
FUCOSIDOSIS      FUCA1
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED      GLB1
#230900 GAUCHER DISEASE, TYPE II;;GD II;;GAUCHER DISEASE, ACUTE NEURONOPATHIC TYPE      GBA
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED      GBA
GAUCHER DISEASE, TYPE IIIC      GBA
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1      ADAMTSL2
3-@HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY      HADH
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED      AAAS
#231670 GLUTARIC ACIDEMIA I;;GLUTARIC ACIDURIA I;;GA I;;GLUTARYL-COA DEHYDROGENASE DEFICIENCY      GCDH
GLYCOGEN STORAGE DISEASE II      GAA
233810 GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA     
#233910 HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B;;HYPERPHENYLALANINEMIA, TETRAHYDROBIOPTERIN-DEFICIENT, DUE TO GTP CYCLOHYDROLASEI DEFICIENCY;;GTP CYCLOHYDROLASE I DEFICIENCYDYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA,AUTOSOMAL RECESSIVE, INCLUDED      GCH1
#234050 TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1; TTDN1;;AMISH BRITTLE HAIR BRAIN SYNDROME; ABHS;;HAIR-BRAIN SYNDROME;;BIDS SYNDROME      MPLKIP
%234100 HALLERMANN-STREIFF SYNDROME; HSS;;FRANCOIS DYSCEPHALIC SYNDROME      GJA1
#234200 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1;;PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; PKAN;;PKAN NEUROAXONAL DYSTROPHY, JUVENILE-ONSET;;HALLERVORDEN-SPATZ DISEASE      PANK2
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME     
HARTNUP DISORDER      SLC6A19
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED     
#235510 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME;;LYMPHATIC DYSPLASIA, GENERALIZED      CCBE1
#235730 MOWAT-WILSON SYNDROME;;MICROCEPHALY, MENTAL RETARDATION, AND DISTINCT FACIAL FEATURES, WITHOR WITHOUT HIRSCHSPRUNG DISEASE;;HIRSCHSPRUNG DISEASE-MENTAL RETARDATION SYNDROME      ZEB2
HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT     
HOLOPROSENCEPHALY      HPE1
#236200 HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY;;HOMOCYSTINURIA WITH OR WITHOUT RESPONSE TO PYRIDOXINE;;CYSTATHIONINE BETA-SYNTHASE DEFICIENCY;;CBS DEFICIENCYHYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED, INCLUDED      CBS
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED      MTHFR
#236670 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 1; MDDGA1;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT1-RELATED;;HYDROCEPHALUS, AGYRIA, AND RETINAL DYSPLASIA;;HARD SYNDROME;;CEREBROOCULAR DYSPLASIA-MUSCULAR DYSTROPHY SYNDROME;;COD-MD SYNDROME      POMT1
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA      L2HGDH
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA     
HYDROXYLYSINURIA     
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY      CPS1
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY      NAGS
HYPER-BETA-ALANINEMIA     
HYPERLEUCINE-ISOLEUCINEMIA     
HYPERLYSINEMIA      AASS
#238970 HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME;;HHH SYNDROME; HHHS; HHH;;ORNITHINE TRANSLOCASE DEFICIENCY      SLC25A15
#239300 HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1; HPMRS1;;MABRY SYNDROME      PIGV
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES     
#239500 HYPERPROLINEMIA, TYPE I; HPI;;PROLINE OXIDASE DEFICIENCY      PRODH
HYPERPROLINEMIA, TYPE II      ALDH4A1
HYPOADRENOCORTICISM, FAMILIAL     
GLYCOGEN STORAGE DISEASE 0, LIVER      GYS2
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH      AKT2
BARTTER SYNDROME, ANTENATAL, TYPE 2      KCNJ1
#241410 HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRD;;HYPOPARATHYROIDISM WITH SHORT STATURE, MENTAL RETARDATION, AND SEIZURES;;SANJAD-SAKATI SYNDROME;;HYPOPARATHYROIDISM, CONGENITAL, ASSOCIATED WITH DYSMORPHISM, GROWTHRETARDATION, AND DEVELOPMENTAL DELAY      TBCE
HYPOPHOSPHATASIA, INFANTILE      ALPL
HYPOPHOSPHATASIA, CHILDHOOD      ALPL
#242840 VICI SYNDROME; VICIS;;IMMUNODEFICIENCY WITH CLEFT LIP/PALATE, CATARACT, HYPOPIGMENTATION,AND ABSENT CORPUS CALLOSUM      EPG5
#243310 BARAITSER-WINTER SYNDROME 1; BRWS1;;IRIS COLOBOMA WITH PTOSIS, HYPERTELORISM, AND MENTAL RETARDATION      ACTB
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID COA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY      IVD
%244300 KAPUR-TORIELLO SYNDROME;;LONG COLUMELLA WITH CLEFT LIP/PALATE AND EYE, HEART, AND INTESTINALANOMALIES     
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE      TBCE
#245150 KEUTEL SYNDROME;;PULMONIC STENOSIS, BRACHYTELEPHALANGISM, AND CALCIFICATION OF CARTILAGES      MGP
KIFAFA SEIZURE DISORDER     
#245200 KRABBE DISEASE;;GLOBOID CELL LEUKODYSTROPHY; GLD; GCL;;GLOBOID CELL LEUKOENCEPHALOPATHY;;GALACTOSYLCERAMIDE BETA-GALACTOSIDASE DEFICIENCY;;GALACTOCEREBROSIDASE DEFICIENCY;;GALC DEFICIENCY      GALC
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY      PDHX
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY      SUCLG1
LANDAU-KLEFFNER SYNDROME     
#246900 DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY; DLDD;;DLD DEFICIENCY;;E3 DEFICIENCY;;LIPOAMIDE DEHYDROGENASE DEFICIENCY, LACTIC ACIDOSIS DUE TO;;MAPLE SYRUP URINE DISEASE, TYPE III      DLD
#247100 LIPOID PROTEINOSIS OF URBACH AND WIETHE;;LIPOID PROTEINOSIS;;URBACH-WIETHE DISEASE;;HYALINOSIS CUTIS ET MUCOSAE      ECM1
#247200 MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS;;MDSCHROMOSOME 17P13.3 DELETION SYNDROME, INCLUDED;;MILLER-DIEKER SYNDROME CHROMOSOME REGION, INCLUDED; MDCR, INCLUDED     
MACDERMOT-WINTER SYNDROME     
HYPOMAGNESEMIA 3, RENAL      CLDN16
#248360 MALONYL-COA DECARBOXYLASE DEFICIENCY      MLYCD
MANNOSIDOSIS, BETA A, LYSOSOMAL      MANBA
MAPLE SYRUP URINE DISEASE      BCKDHA ; BCKDHB ; DBT
%248700 MARDEN-WALKER SYNDROME;;MWS     
248910 CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA     
MEGALENCEPHALY WITH DYSMYELINATION     
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA      SLC19A2
%249310 MEGALOCORNEA-MENTAL RETARDATION SYNDROME;;MMR SYNDROME;;NEUHAUSER SYNDROME     
249400 MELANOSIS, NEUROCUTANEOUS     
MENTAL RETARDATION SYNDROME, BELGIAN TYPE     
MENTAL RETARDATION, CONGENITAL HEART DISEASE, BLEPHAROPHIMOSIS, BLEPHAROPTOSIS,AND HYPOPLASTIC TEETH     
MERCAPTOLACTATE-CYSTEINE DISULFIDURIA     
#249900 METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY;;METACHROMATIC LEUKODYSTROPHY DUE TO CEREBROSIDE SULFATASE ACTIVATORDEFICIENCY;;SAPOSIN B DEFICIENCY      PSAP
#250100 METACHROMATIC LEUKODYSTROPHY;;MLD;;METACHROMATIC LEUKOENCEPHALOPATHY;;CEREBRAL SCLEROSIS, DIFFUSE, METACHROMATIC FORM;;SULFATIDE LIPIDOSIS;;ARYLSULFATASE A DEFICIENCY;;ARSA DEFICIENCY;;CEREBROSIDE SULFATASE DEFICIENCYPSEUDOARYLSULFATASE A DEFICIENCY, INCLUDED;;METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE, INCLUDED;;METACHROMATIC LEUKODYSTROPHY, JUVENILE, INCLUDED;;METACHROMATIC LEUKODYSTROPHY, ADULT, INCLUDED      ARSA
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE     
3-@METHYLGLUTACONIC ACIDURIA, TYPE I      AUH
250951 3-@METHYLGLUTACONIC ACIDURIA, TYPE IV; MGCA4;;MGA, TYPE IV; MGA4     
#251000 METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY;;METHYLMALONIC ACIDEMIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCYMMA DUE TO MCM DEFICIENCY;;METHYLMALONIC ACIDURIA, MUT TYPEMETHYLMALONIC ACIDURIA, MUT(0) TYPE, INCLUDED;;METHYLMALONIC ACIDURIA, MUT(-) TYPE, INCLUDED      MUT
#251100 METHYLMALONIC ACIDURIA, CBLA TYPE;;METHYLMALONIC ACIDEMIA, CBLA TYPE;;METHYLMALONIC ACIDURIA, VITAMIN B12-RESPONSIVE, DUE TO DEFECT IN SYNTHESISOF ADENOSYLCOBALAMIN, CBLA TYPE      MMAA
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1      MCPH1
MICROCEPHALY-CARDIOMYOPATHY     
MICROCEPHALY WITH CHORIORETINOPATHY, AUTOSOMAL RECESSIVECHORIORETINAL DYSPLASIA-MICROCEPHALY-MENTAL RETARDATION SYNDROME,INCLUDED      TUBGCP6
251280 MICROCEPHALY WITH SPASTIC QUADRIPLEGIA     
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME      OCLN
MICROCEPHALY, HIATUS HERNIA, AND NEPHROTIC SYNDROME     
#251880 MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE); MTDPS3      DGUOK
251950 MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS     
#252010 MITOCHONDRIAL COMPLEX I DEFICIENCY;;NADH:Q(1) OXIDOREDUCTASE DEFICIENCY;;NADH-COENZYME Q REDUCTASE DEFICIENCY;;MITOCHONDRIAL NADH DEHYDROGENASE COMPONENT OF COMPLEX I, DEFICIENCYOF      NDUFAF3 ; NDUFAF1 ; NDUFB3 ; NDUFA11 ; NDUFAF4 ; NDUFS1 ; NDUFAF2 ; NDUFS3 ; NDUFV1 ; NDUFS2 ; NDUFAF5 ; NDUFS6 ; NDUFA1 ; NDUFS4 ; NUBPL ; FOXRED1 ; NDUFV2
MITOCHONDRIAL COMPLEX II DEFICIENCY      SDHA ; SDHAF1
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II     
MOLYBDENUM COFACTOR DEFICIENCY      GPHN ; MOCS2 ; MOCS1
MONOSOMY 7 OF BONE MARROW     
MUCOPOLYSACCHARIDOSIS TYPE IIIA      SGSH
MUCOPOLYSACCHARIDOSIS TYPE IIIB      NAGLU
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-COA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY      HGSNAT
#252940 MUCOPOLYSACCHARIDOSIS TYPE IIID;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY      GNS
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET      BTD
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY      HLCS
#253280 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 3; MDDGA3;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMGNT1-RELATED      POMGNT1
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY     
#253800 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 4; MDDGA4;;FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; FCMD;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, FKTN-RELATED      FKTN
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED     
#254780 MYOCLONIC EPILEPSY OF LAFORA;;MELF;;LAFORA DISEASE;;LAFORA BODY DISEASE; LBD;;EPILEPSY, PROGRESSIVE MYOCLONIC 2A; EPM2A;;EPM2EPILEPSY, PROGRESSIVE MYOCLONIC 2B, INCLUDED; EPM2B, INCLUDED      EPM2A ; NHLRC1
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG      CSTB
#254900 EPILEPSY, PROGRESSIVE MYOCLONIC 4, WITH OR WITHOUT RENAL FAILURE;EPM4;;ACTION MYOCLONUS-RENAL FAILURE SYNDROME; AMRF;;MYOCLONUS-NEPHROPATHY SYNDROME      SCARB2
#255120 CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY;;CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY;;CPT I DEFICIENCY;;CPT DEFICIENCY, HEPATIC, TYPE I      CPT1A
#256000 LEIGH SYNDROME; LS;;NECROTIZING ENCEPHALOPATHY, INFANTILE SUBACUTE, OF LEIGH; SNELEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX II DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX III DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX V DEFICIENCY, INCLUDED      NDUFS7 ; NDUFA10 ; NDUFA9 ; SDHA ; BCS1L ; NDUFAF2 ; SURF1 ; NDUFA12 ; NDUFS3 ; COX15 ; NDUFS4 ; NDUFA2 ; NDUFS8 ; FOXRED1 ; NDUFAF6
#256040 AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD;;NAKAJO-NISHIMURA SYNDROME; NKJO;;JOINT CONTRACTURES, MUSCULAR ATROPHY, MICROCYTIC ANEMIA, AND PANNICULITIS-INDUCEDLIPODYSTROPHY; JMP SYNDROME;;CHRONIC ATYPICAL NEUTROPHILIC DERMATOSIS WITH LIPODYSTROPHY AND ELEVATEDTEMPERATURE SYNDROME; CANDLE      PSMB8
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1      ABCC8
#256500 NETHERTON SYNDROME; NETH;;NS;;NETHERTON DISEASE      SPINK5
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY      CTSA
NEURAMINIDASE DEFICIENCY      NEU1
#256600 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A;;NEUROAXONAL DYSTROPHY, INFANTILE; INAD1;;INAD;;NEURODEGENERATION, PLA2G6-ASSOCIATED; PLAN;;SEITELBERGER DISEASE      PLA2G6
ELEJALDE DISEASE     
CEROID LIPOFUSCINOSIS, NEURONAL, 1      PPT1
CEROID LIPOFUSCINOSIS, NEURONAL, 5      CLN5
NIEMANN-PICK DISEASE, TYPE C1      NPC1
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME      BUB1B
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS     
OLIVER SYNDROME     
OSSIFIED EAR CARTILAGES WITH MENTAL DEFICIENCY, MUSCLE WASTING, AND     
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE     
#259700 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1;;OSTEOPETROSIS, INFANTILE MALIGNANT 1;;MARBLE BONES, AUTOSOMAL RECESSIVE;;ALBERS-SCHONBERG DISEASE, AUTOSOMAL RECESSIVE      TCIRG1
PAPILLOMA OF CHOROID PLEXUS      TP53
PEHO SYNDROME     
#260600 LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3      AIMP1
HYPER-IGD SYNDROME      MVK
#261515 D-BIFUNCTIONAL PROTEIN DEFICIENCY;;17-@BETA-HYDROXYSTEROID DEHYDROGENASE IV DEFICIENCY;;DBP DEFICIENCY;;PEROXISOMAL BIFUNCTIONAL ENZYME DEFICIENCY;;PBFE DEFICIENCY      HSD17B4
#261540 PETERS-PLUS SYNDROME;;KRAUSE-KIVLIN SYNDROME;;PETERS ANOMALY WITH SHORT-LIMB DWARFISM      B3GALTL
#261600 PHENYLKETONURIA; PKU;;PHENYLALANINE HYDROXYLASE DEFICIENCY;;PAH DEFICIENCY;;OLIGOPHRENIA PHENYLPYRUVICA;;FOLLING DISEASEHYPERPHENYLALANINEMIA, NON-PKU MILD, INCLUDED;;HPA, NON-PKU MILD, INCLUDED;;PHENYLKETONURIA, MATERNAL, INCLUDED      PAH
PHENYLKETONURIA II      QDPR
6-@PYRUVOYLTETRAHYDROPTERIN SYNTHASE      PTS
261680 PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC;;PCK1 DEFICIENCY, CYTOSOLIC;;PEPCK DEFICIENCY, CYTOSOLIC      PCK1
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM      PROP1
#263800 GITELMAN SYNDROME;;HYPOMAGNESEMIA-HYPOKALEMIA, PRIMARY RENOTUBULAR, WITH HYPOCALCIURIA;;POTASSIUM AND MAGNESIUM DEPLETION      SLC12A3
#264470 PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-COA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY      ACOX1
PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES     
#264700 VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A;;VITAMIN D-DEPENDENT RICKETS, TYPE 1A;;1@-ALPHA, 25-HYDROXYVITAMIN D3 DEFICIENCY, SELECTIVE;;25-@HYDROXYCHOLECALCIFEROL-1-HYDROXYLASE DEFICIENCY;;1-@ALPHA-HYDROXYLASE DEFICIENCY;;VITAMIN D DEPENDENCY, TYPE 1; VDD1;;PSEUDOVITAMIN D-DEFICIENCY RICKETS, TYPE IA; PDDR1A;;PDDR IA      CYP27B1
#266100 EPILEPSY, PYRIDOXINE-DEPENDENT; EPD;;PYRIDOXINE-DEPENDENT EPILEPSY; PDE;;PYRIDOXINE DEPENDENCY WITH SEIZURES;;AASA DEHYDROGENASE DEFICIENCY      ALDH7A1
#266130 GLUTATHIONE SYNTHETASE DEFICIENCY;;5-@OXOPROLINURIA;;PYROGLUTAMIC ACIDURIA      GSS
PYRUVATE CARBOXYLASE DEFICIENCY      PC
#266265 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C;;CDG IIC; CDGIIC;;LEUKOCYTE ADHESION DEFICIENCY, TYPE II; LAD2;;RAMBAM-HASHARON SYNDROME; RHS      SLC35C1
RAMON SYNDROME     
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR      DIS3L2
%267700 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1; FHL1;;HPLH1;;HLH1;;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL; FHL; FHLH; HPLH;;RETICULOSIS, FAMILIAL HISTIOCYTIC;;HEMOPHAGOCYTIC RETICULOSIS, FAMILIAL;;ERYTHROPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL; FEL      HPLH1
RETINAL DEGENERATION AND EPILEPSY     
KNOBLOCH SYNDROME, TYPE I      COL18A1
SANDHOFF DISEASE      HEXB
SC PHOCOMELIA SYNDROME      ESCO2
#269150 SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME;;SGS      SETBP1
SCHIZENCEPHALY      SHH ; EMX2 ; SIX3
%269200 AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II; APS2;;SCHMIDT SYNDROME;;DIABETES MELLITUS, ADDISON DISEASE, MYXEDEMA;;POLYGLANDULAR AUTOIMMUNE SYNDROME, TYPE II;;PGA II;;POLYENDOCRINE AUTOIMMUNE SYNDROME, TYPE II;;APS II     
EPILEPSY, BENIGN NEONATAL, AUTOSOMAL RECESSIVE     
INFANTILE SIALIC ACID STORAGE DISORDER      SLC17A5
#269921 SIALURIA;;SIALURIA, FRENCH TYPE      GNE
SJOGREN-LARSSON SYNDROME      ALDH3A2
#270400 SMITH-LEMLI-OPITZ SYNDROME; SLOS;;SLO SYNDROME;;RSH SYNDROME;;RUTLEDGE LETHAL MULTIPLE CONGENITAL ANOMALY SYNDROME;;POLYDACTYLY, SEX REVERSAL, RENAL HYPOPLASIA, AND UNILOBAR LUNG;;LETHAL ACRODYSGENITAL SYNDROME      DHCR7
INFANTILE-ONSET SPINOCEREBELLAR ATAXIA      C10ORF2
#271900 CANAVAN DISEASE;;CANAVAN-VAN BOGAERT-BERTRAND DISEASE;;SPONGY DEGENERATION OF CENTRAL NERVOUS SYSTEM;;ASPARTOACYLASE DEFICIENCY;;ASPA DEFICIENCY;;ASP DEFICIENCY;;AMINOACYLASE 2 DEFICIENCY;;ACY2 DEFICIENCY      ASPA
#271980 SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; SSADHD;;SSADH DEFICIENCY;;4-@HYDROXYBUTYRIC ACIDURIA;;GABA METABOLIC DEFECT;;GAMMA-HYDROXYBUTYRIC ACIDURIA      ALDH5A1
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE      SUMF1
#272300 SULFOCYSTEINURIA;;SULFITE OXIDASE DEFICIENCY      SUOX
#272430 COLD-INDUCED SWEATING SYNDROME 1; CISS1;;CRISPONI SYNDROME;;SOHAR-CRISPONI SYNDROME;;MUSCLE CONTRACTIONS, TETANOFORM, WITH CHARACTERISTIC FACE, CAMPTODACTYLY,HYPERTHERMIA, AND SUDDEN DEATH      CRLF1
%272440 SYNDACTYLY, TYPE I, WITH MICROCEPHALY AND MENTAL RETARDATION;;FILIPPI SYNDROME     
TACHYCARDIA, HYPERTENSION, MICROPHTHALMIA, AND HYPERGLYCINURIA     
TAY-SACHS DISEASE, AB VARIANT      GM2A
TAY-SACHS DISEASE      HEXA
INFANTILE SYMMETRICAL THALAMIC DEGENERATION     
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME     
THREONINEMIA     
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1Q21.1 DELETION SYNDROME, 200-KB      RBM8A
THYROCEREBRORETINAL SYNDROME     
#274270 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY;;DPD DEFICIENCY;;DPYD DEFICIENCY;;THYMINE-URACILURIA, HEREDITARY;;PYRIMIDINEMIA, FAMILIAL5-@FLUOROURACIL TOXICITY, INCLUDED      DPYD
#276300 MISMATCH REPAIR CANCER SYNDROME;;MMRCS;;MISMATCH REPAIR DEFICIENCY;;MMR DEFICIENCY;;CHILDHOOD CANCER SYNDROME;;BRAIN TUMOR-POLYPOSIS SYNDROME 1; BTPS1;;BTP1 SYNDROME;;TURCOT SYNDROME      MSH2 ; MSH6 ; MLH1 ; PMS2
TYROSINE TRANSAMINASE DEFICIENCY      TAT
TYROSINEMIA, TYPE III      HPD
#277400 METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE;;METHYLMALONIC ACIDEMIA AND HOMOCYSTINURIA, CBLC TYPE;;METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, VITAMIN B12-RESPONSIVE;;VITAMIN B12 METABOLIC DEFECT WITH COMBINED DEFICIENCY OF METHYLMALONYL-COAMUTASE AND HOMOCYSTEINE:METHYLTETRAHYDROFOLATE METHYLTRANSFERASE      MMACHC
#277410 METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE;;METHYLMALONIC ACIDEMIA AND HOMOCYSTINURIA, CBLD TYPEHOMOCYSTINURIA, CBLD TYPE, VARIANT 1, INCLUDED;;METHYLMALONIC ACIDURIA, CBLD TYPE, VARIANT 2, INCLUDED;;METHYLMALONIC ACIDURIA, CBLH TYPE, FORMERLY;;METHYLMALONIC ACIDEMIA, CBLH TYPE, FORMERLY      MMADHC
#277440 VITAMIN D-DEPENDENT RICKETS, TYPE 2A; VDDR2A;;VITAMIN D-DEPENDENT RICKETS, TYPE 2A, WITH OR WITHOUT ALOPECIA;;RICKETS, HEREDITARY VITAMIN D-RESISTANT; HVDRR;;GENERALIZED RESISTANCE TO 1,25-DIHYDROXYVITAMIN D;;VITAMIN D-RESISTANT RICKETS WITH END-ORGAN UNRESPONSIVENESS TO 1,25-DIHYDROXYCHOLECALCIFEROL;;PSEUDOVITAMIN D-DEFICIENCY, TYPE IIA;;PDDR IIA;;HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS; HVDRR;;RICKETS-ALOPECIA SYNDROME      VDR
#277470 PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A;;PCH2;;PONTOCEREBELLAR HYPOPLASIA WITH PROGRESSIVE CEREBRAL ATROPHY;;VOLENDAM NEURODEGENERATIVE DISEASE      TSEN54
#277590 WEAVER SYNDROME 1; WVS1;;WEAVER-SMITH SYNDROME; WSSWEAVER-LIKE SYNDROME, INCLUDED      EZH2
INTELLECTUAL DEFICIT, WOLFF TYPE     
#278250 WRINKLY SKIN SYNDROME; WSS      ATP6V0A2
XYLOSIDASE DEFICIENCY     
#280000 COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTALRETARDATION, AND EAR ANOMALIES SYNDROME; CHIME;;CHIME SYNDROME;;ZUNICH NEUROECTODERMAL SYNDROME      PIGL
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME      ARX
#300048 INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED;;IPOX;;CONGENITAL IDIOPATHIC INTESTINAL PSEUDOOBSTRUCTION; CIIP;;CIIP, X-LINKED; CIIPX;;INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, WITH CENTRALNERVOUS SYSTEM INVOLVEMENTCONGENITAL SHORT BOWEL SYNDROME, INCLUDED; CSBS, INCLUDED      FLNA
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED      FLNA
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13      MECP2
MENTAL RETARDATION, X-LINKED 14      MRX14
#300067 LISSENCEPHALY, X-LINKED, 1; LISX1;;XLIS;;LISSENCEPHALY AND AGENESIS OF CORPUS CALLOSUMSUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED, INCLUDED; SCLH, INCLUDED;;SUBCORTICAL BAND HETEROTOPIA, X-LINKED, INCLUDED; SBH, INCLUDED;;DOUBLE CORTEX SYNDROME, INCLUDED;;DC SYNDROME, INCLUDED      DCX
EPILEPSY, FEMALE-RESTRICTED, WITH MENTAL RETARDATION      PCDH19
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34      IL1RAPL1
MEHMO SYNDROME      MEHMO
#300215 LISSENCEPHALY, X-LINKED, 2; LISX2;;LISSENCEPHALY, X-LINKED, WITH AMBIGUOUS GENITALIA; XLAG;;XLISGHYDRANENCEPHALY AND ABNORMAL GENITALIA, INCLUDED      ARX
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION     
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11      MRXS11
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE      SLC9A6
LUBS X-LINKED MENTAL RETARDATION SYNDROME      MECP2
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE     
300270 ADRENOMYODYSTROPHY     
MENTAL RETARDATION, X-LINKED 72      RAB39B ; MRX72
HYPOMELANOSIS OF ITO      HMI
#300352 CREATINE DEFICIENCY SYNDROME, X-LINKED;;CREATINE TRANSPORTER DEFECT;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, SHORT STATURE, AND MIDFACEHYPOPLASIA;;MENTAL RETARDATION, X-LINKED, WITH CREATINE TRANSPORT DEFICIENCY      SLC6A8
#300354 MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, ANDABNORMAL GAIT;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 15; MRXS15;;CABEZAS X-LINKED MENTAL RETARDATION SYNDROME; MRXSC;;CABEZAS SYNDROME      CUL4B
MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE     
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS      AMER1
POLYMICROGYRIA, BILATERAL PERISYLVIAN     
INTELLECTUAL DEFICIT, X-LINKED, WITTWER TYPE     
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED      CASK
#300423 MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH;;MENTAL RETARDATION, X-LINKED, WITH EPILEPSY; MRXE      ATP6AP2
AUTISM, X-LINKED, SUSCEPTIBILITY TO, 1AUTSX1     
ATKIN-FLAITZ SYNDROME     
#300438 17-@BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY;;HSD17B10 DEFICIENCY;;HSD10 DEFICIENCY;;3-@HYDROXYACYL-COA DEHYDROGENASE II DEFICIENCY;;2-@METHYL-3-HYDROXYBUTYRYL-COA DEHYDROGENASE DEFICIENCY;;MHBD DEFICIENCY      HSD17B10
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES     
#300486 MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVEFACIAL APPEARANCE;;MENTAL RETARDATION, X-LINKED 60, FORMERLY; MRX60, FORMERLY      OPHN1
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS      SYN1
AUTISM, X-LINKED, SUSCEPTIBILITY TO, 2      NLGN4X
AUTISM, X-LINKED, SUSCEPTIBILITY TO, 3     
MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED      KDM5C
EHLERS-DANLOS SYNDROME WITH PERIVENTRICULAR HETEROTOPIA      FLNA
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS      AVPR2
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47      PAK3
CLARK-BARAITSER SYNDROME     
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY      ARHGEF9
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB     
FRAGILE X MENTAL RETARDATION SYNDROME      FMR1
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX      SRPX2
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY      PGK1
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2;;RETT SYNDROME, VARIANT, WITH INFANTILE SPASMS;;RETT SYNDROME, ATYPICAL, CDKL5-RELATED      CDKL5
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS      MECP2
#300699 MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW;;MENTAL RETARDATION, X-LINKED 94; MRX94;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 29; MRXS29      GRIA3
SYNDACTYLY - TELECANTHUS - ANOGENITAL AND RENAL MALFORMATIONS      FAM58A
#300749 MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA;MICPCH;;MICPCH SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, NAJM TYPE; MRXSNA      CASK
#300801 CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME     
#300802 MENTAL RETARDATION, X-LINKED 96; MRX96      SYP
#300816 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6;;ENCEPHALOMYOPATHY, MITOCHONDRIAL, X-LINKED      AIFM1
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION      NSDHL
#300842 MCLEOD SYNDROME; MCLDS;;MCLEOD PHENOTYPE;;NEUROACANTHOCYTOSIS, MCLEOD TYPEMCLEOD SYNDROME WITH CHRONIC GRANULOMATOUS DISEASE, INCLUDED      XK
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE     
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89      ZNF41
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30      UBE2A
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE     
300864 CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED     
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2      PIGA
#300872 EPSILON-TRIMETHYLLYSINE HYDROXYLASE DEFICIENCY; TMLHED;;AUTISM, SUSCEPTIBILITY TO, X-LINKED 6; AUTSX6      TMLHE
#300882 CORNELIA DE LANGE SYNDROME 5; CDLS5      HDAC8
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32      CLIC2
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA      WDR45
#301040 ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX;;ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE;;ATR-X SYNDROME;;ATR, NONDELETION TYPE      ATRX
%301220 PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS; PDR;;AMYLOIDOSIS, FAMILIAL CUTANEOUS      PDR
FABRY DISEASE      GLA
301790 SPINOCEREBELLAR ATAXIA, X-LINKED 3;;SCAX3;;ATAXIA-DEAFNESS SYNDROME, X-LINKED      SCAX3
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1      UBA1
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18      PRPS1
BORJESON-FORSSMAN-LEHMANN SYNDROME      PHF6
%302380 CATEL-MANZKE SYNDROME;;HYPERPHALANGY-CLINODACTYLY OF INDEX FINGER WITH PIERRE ROBIN SYNDROME;;PIERRE ROBIN SYNDROME WITH HYPERPHALANGY AND CLINODACTYLY;;INDEX FINGER ANOMALY WITH PIERRE ROBIN SYNDROME;;PALATODIGITAL SYNDROME, CATEL-MANZKE TYPE;;MICROGNATHIA DIGITAL SYNDROME     
#303600 COFFIN-LOWRY SYNDROME; CLS      RPS6KA3
%304050 AICARDI SYNDROME; AIC;;CORPUS CALLOSUM, AGENESIS OF, WITH CHORIORETINAL ABNORMALITY      AIC
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED      L1CAM
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED      AVPR2
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME      MED12
306960 HHHH SYNDROME;;HEREDITARY HEMIHYPOTROPHY HEMIPARESIS HEMIATHETOSIS SYNDROME     
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS      L1CAM
#307030 HYPERGLYCEROLEMIA;;GLYCEROL KINASE DEFICIENCY;;GK DEFICIENCY; GKD;;GK1 DEFICIENCY      GK
HYPOPARATHYROIDISM, X-LINKED      HPT
ICHTHYOSIS, X-LINKED      STS
ICHTHYOSIS AND MALE HYPOGONADISMRUD SYNDROME, INCLUDED     
#308205 IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME;;ICHTHYOSIS FOLLICULARIS, ATRICHIA, AND PHOTOPHOBIA WITH OR WITHOUTBRAIN ANOMALIES, RETARDATION, ECTODERMAL DYSPLASIA, SKELETAL MALFORMATIONS,HIRSCHSPRUNG DISEASE, EAR/EYE ANOMALIES, CLEFT PALATE/CRYPTORCHIDISM,AND KIDNEY DYSPLASIA/HYPOPLASIA      MBTPS2
#308300 INCONTINENTIA PIGMENTI; IP;;INCONTINENTIA PIGMENTI, FAMILIAL MALE-LETHAL TYPE;;BLOCH-SULZBERGER SYNDROME;;INCONTINENTIA PIGMENTI, TYPE II, FORMERLY; IP2, FORMERLY      IKBKG
#308350 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1;;INFANTILE SPASM SYNDROME, X-LINKED 1; ISSX1;;WEST SYNDROME, X-LINKED;;OHTAHARA SYNDROME, X-LINKED;;INFANTILE EPILEPTIC-DYSKINETIC ENCEPHALOPATHY;;XMESID      ARX
#309000 LOWE OCULOCEREBRORENAL SYNDROME; OCRL;;OCRL1;;LOWE SYNDROME;;PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 5-PHOSPHATASE DEFICIENCY      OCRL
MENKES DISEASE      ATP7A
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS     
#309500 RENPENNING SYNDROME 1; RENS1;;MENTAL RETARDATION, X-LINKED, RENPENNING TYPE;;SUTHERLAND-HAAN X-LINKED MENTAL RETARDATION SYNDROME; SHS;;GOLABI-ITO-HALL SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH SPASTIC DIPLEGIA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 3; MRXS3;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 8; MRXS8;;MENTAL RETARDATION, X-LINKED 55; MRX55      PQBP1
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36      ARX
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS      MED12
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12     
#309549 MENTAL RETARDATION, X-LINKED 9; MRX9;;MENTAL RETARDATION, X-LINKED 44; MRX44      FTSJ1
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES     
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1      ATRX
MENTAL RETARDATION, X-LINKED, SNYDER-ROBINSON TYPE      SMS
#309585 WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 6; MRXS6;;MENTAL RETARDATION, X-LINKED, WITH GYNECOMASTIA AND OBESITY      HDAC8 ; WTS
PRIETO X-LINKED MENTAL RETARDATION SYNDROME      PRS
MICROPHTHALMIA, SYNDROMIC 7      HCCS
#309900 MUCOPOLYSACCHARIDOSIS TYPE II;;MPS II; MPS2;;HUNTER SYNDROME;;IDURONATE 2-SULFATASE DEFICIENCY;;IDS DEFICIENCY;;SULFOIDURONATE SULFATASE DEFICIENCY;;SIDS DEFICIENCY      IDS
310370 MYOCLONIC EPILEPSY, PROGRESSIVE     
NORRIE DISEASE      NDP
#311200 OROFACIODIGITAL SYNDROME I; OFD1;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE I;;OFDS I;;PAPILLON-LEAGE AND PSAUME SYNDROME      OFD1
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED      OTC
PAINE SYNDROME      MSD
311450 PALLISTER W SYNDROME;;W SYNDROME     
PARKINSONISM, EARLY-ONSET, WITH MENTAL RETARDATION      WSN
#312080 PELIZAEUS-MERZBACHER DISEASE; PMD;;LEUKODYSTROPHY, HYPOMYELINATING, 1; HLD1      PLP1
#312170 PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD;;PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY;;PYRUVATE DECARBOXYLASE DEFICIENCY;;ATAXIA, INTERMITTENT, WITH ABNORMAL PYRUVATE METABOLISM;;PDH DEFICIENCY;;ATAXIA, INTERMITTENT, WITH PYRUVATE DEHYDROGENASE DEFICIENCY;;ATAXIA WITH LACTIC ACIDOSIS ILACTIC ACIDEMIA, THIAMINE-RESPONSIVE, INCLUDED      PDHA1
RETT SYNDROME      MECP2
312860 SCOTT CRANIODIGITAL SYNDROME WITH MENTAL RETARDATION     
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1      GPC3
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY     
CYCLIC VOMITING SYNDROME     
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS     
KEARNS-SAYRE SYNDROME     
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKEEPISODES     
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS     
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA     
WOLFRAM SYNDROME, MITOCHONDRIAL FORM     
#600001 PANCREATIC AGENESIS AND CONGENITAL HEART DEFECTS; PACHD;;PANCREATIC HYPOPLASIA, CONGENITAL, WITH DIABETES MELLITUS AND CONGENITALHEART DISEASE      GATA6
600096 PUERTO RICAN INFANT HYPOTONIA SYNDROME     
EPILEPSY, CHILDHOOD ABSENCE, 1      ECA1
CEROID LIPOFUSCINOSIS, NEURONAL, 8      CLN8
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES     
LOWRY-MACLEAN SYNDROME     
FRYNS MACROCEPHALY     
BAND HETEROTOPIA OF BRAIN     
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT      NIPA1
#600376 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED,INCLUDED      ACVRL1
#600430 BRACHYDACTYLY-MENTAL RETARDATION SYNDROME; BDMR;;ALBRIGHT HEREDITARY OSTEODYSTROPHY-LIKE SYNDROMECHROMOSOME 2Q37 DELETION SYNDROME, INCLUDED      HDAC4 ; BDMR
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS     
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT      LGI1
#600513 EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1      CHRNA4
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE      CPT2
EPILEPSY, IDIOPATHIC GENERALIZED      EGI
600679 DERMOID CYSTS, FAMILIAL FRONTONASAL     
#600721 D-2-@HYDROXYGLUTARIC ACIDURIA 1;;D2HGA;;D2HGA1      D2HGDH
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1      FCMTE1
ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMALDOMINANT     
HARROD SYNDROME     
#601110 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D;;CDG ID; CDGID;;CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE IV, FORMERLY; CDGS4,FORMERLY;;CDGS, TYPE IV, FORMERLY      ALG3
GURRIERI SYNDROME     
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM     
POTOCKI-SHAFFER SYNDROME     
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE     
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION     
#601358 NICOLAIDES-BARAITSER SYNDROME; NCBRS;;SPARSE HAIR AND MENTAL RETARDATION;;NBS      SMARCA2
#601378 CRISPONI SYNDROME;;MUSCLE CONTRACTIONS, TETANOFORM, WITH CHARACTERISTIC FACE, CAMPTODACTYLY,HYPERTHERMIA, AND SUDDEN DEATH     
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE     
#601539 PEROXISOME BIOGENESIS DISORDER 1B; PBD1B;;PEROXISOME BIOGENESIS DISORDER (NEONATAL ADRENOLEUKODYSTROPHY/INFANTILEREFSUM DISEASE);;PEROXISOME BIOGENESIS DISORDER (NALD/IRD);;ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL;;REFSUM DISEASE, INFANTILE;;INFANTILE PHYTANIC ACID STORAGE DISEASE      PEX1
%601612 LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME;LACHT;;MARDINI-NYHAN ASSOCIATION     
#601675 TRICHOTHIODYSTROPHY, PHOTOSENSITIVE; TTDPICHTHYOSIFORM ERYTHRODERMA WITH HAIR ABNORMALITY AND MENTAL AND GROWTHRETARDATION, INCLUDED;;TAY SYNDROME, INCLUDED;;TRICHOTHIODYSTROPHY WITH CONGENITAL ICHTHYOSIS, INCLUDED;;ICHTHYOSIS, CONGENITAL, WITH TRICHOTHIODYSTROPHY, INCLUDED;;IBIDS SYNDROME, INCLUDED      GTF2H5 ; ERCC2 ; ERCC3
BARTTER SYNDROME, ANTENATAL, TYPE 1      SLC12A1
CONVULSIONS, BENIGN FAMILIAL INFANTILE, 1     
CEROID LIPOFUSCINOSIS, NEURONAL, 6      CLN6
#601803 PALLISTER-KILLIAN SYNDROME; PKS;;TETRASOMY 12P, MOSAIC;;ISOCHROMOSOME 12P SYNDROMEHEXASOMY 12P, MOSAIC, INCLUDED     
#601808 CHROMOSOME 18Q DELETION SYNDROME;;CHROMOSOME 18Q- SYNDROME;;18Q- SYNDROME     
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY      PHGDH
601853 CEREBELLOTRIGEMINAL DERMAL DYSPLASIA;;GOMEZ-LOPEZ-HERNANDEZ SYNDROME;;GLH SYNDROME;;CEREBELLO-TRIGEMINAL-DERMAL DYSPLASIA     
HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA      TRPM6
CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS      ICCA ; PRRT2
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC     
%602342 PLANTAR LIPOMATOSIS, UNUSUAL FACIES, AND DEVELOPMENTAL DELAY;;PIERPONT SYNDROME     
#602398 DESMOSTEROLOSIS      DHCR24
#602473 ENCEPHALOPATHY, ETHYLMALONIC; EE      ETHE1
%602477 FEBRILE SEIZURES, FAMILIAL, 2; FEB2;;CONVULSIONS, FAMILIAL FEBRILE, 2      FEB2
MIGRAINE, FAMILIAL HEMIPLEGIC, 2      ATP1A2
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3      GCK
#602501 MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP;;MACROCEPHALY-CAPILLARY MALFORMATION; MCM;;MEGALENCEPHALY-CAPILLARY MALFORMATION SYNDROME;;MACROCEPHALY-CUTIS MARMORATA TELANGIECTATICA CONGENITA; MCMTC;;MEGALENCEPHALY-CUTIS MARMORATA TELANGIECTATICA CONGENITA      PIK3CA
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES      CHKB
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION,LETHAL     
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC      ALG6
%603204 EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2     
CEREBRAL CAVERNOUS MALFORMATIONS 2      CCM2
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3      PDCD10
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT      PIK3R2 ; PIK3CA ; AKT3
NEURONAL INTRANUCLEAR INCLUSION DISEASE     
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE      GAD1
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10      ATXN10
#603553 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2;;HPLH2;;HLH2      PRF1
BLEPHAROPHIMOSIS-INTELLECTUAL DEFICIT SYNDROME, SBBYS TYPE      KAT6B
#603896 LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM;;CHILDHOOD ATAXIA WITH CENTRAL NERVOUS SYSTEM HYPOMYELINIZATION; CACH;;VANISHING WHITE MATTER LEUKODYSTROPHY;;CREE LEUKOENCEPHALOPATHY; CLEVANISHING WHITE MATTER LEUKODYSTROPHY WITH OVARIAN FAILURE, INCLUDED;;OVARIOLEUKODYSTROPHY, INCLUDED      EIF2B2 ; EIF2B5 ; EIF2B4 ; EIF2B3 ; EIF2B1
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS      MLC1
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82      GPSM2
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB      SERPINI1
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1      SCN1B
ATPASE DEFICIENCY, NUCLEAR-ENCODED      ATPAF2
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2      WDR62
FEBRILE CONVULSIONS, FAMILIAL, 4      GPR98
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC      SPG11
#604369 SIALURIA, FINNISH TYPE;;SALLA DISEASE; SD      SLC17A5
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED      SCN1A
CRANIOSYNOSTOSIS, BOSTON TYPE      MSX2
#604772 VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH ORWITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1;;VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC; VTSIP      RYR2
HUNTINGTON DISEASE-LIKE 3     
MYOCLONIC EPILEPSY, JUVENILE, 2      EJM2
%605013 MICROHYDRANENCEPHALY; MHAC;;HYDRANENCEPHALY AND MICROCEPHALY      MHAC
#605021 MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME;;EIM      TBC1D24
#605039 BOHRING-OPITZ SYNDROME; BOPS;;C-LIKE SYNDROME;;OPITZ TRIGONOCEPHALY-LIKE SYNDROME;;BOHRING SYNDROME      ASXL1
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID ANDPRION PATHOLOGY     
#605130 HAIRY ELBOWS, SHORT STATURE, FACIAL DYSMORPHISM, AND DEVELOPMENTALDELAY;;WIEDEMANN-STEINER SYNDROME; WDSTS      KMT2A
#605714 CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED;;AMYLOIDOSIS, CEREBROARTERIAL, APP-RELATED;;AMYLOIDOSIS, HEREDITARY, WITH CEREBRAL HEMORRHAGE, DUTCH VARIANT;HCHWAD;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, DUTCH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT      APP
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2      PRRT2
#605899 GLYCINE ENCEPHALOPATHY; GCE;;HYPERGLYCINEMIA, NONKETOTIC; NKHHYPERGLYCINEMIA, TRANSIENT NEONATAL, INCLUDED; TNH, INCLUDED      AMT ; GLDC ; GCSH
3-HYDROXY 3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY      HMGCS2
#606054 PROPIONIC ACIDEMIA;;PROPIONYL-COA CARBOXYLASE DEFICIENCY;;PCC DEFICIENCY;;GLYCINEMIA, KETOTIC;;HYPERGLYCINEMIA WITH KETOACIDOSIS AND LEUKOPENIA;;KETOTIC HYPERGLYCINEMIA      PCCB ; PCCA
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB      MOGS
606155 FRYNS-AFTIMOS SYNDROME;;PACHYGYRIA, MENTAL RETARDATION, EPILEPSY, AND CHARACTERISTIC FACIES;;CEREBROOCULOFACIAL LYMPHATIC SYNDROME;;COFL SYNDROME;;MENTAL RETARDATION WITH EPILEPSY AND CHARACTERISTIC FACIES     
#606170 GENITOPATELLAR SYNDROME; GTPTS;;ABSENT PATELLAE, SCROTAL HYPOPLASIA, RENAL ANOMALIES, FACIAL DYSMORPHISM,AND MENTAL RETARDATION      KAT6B
DIABETES MELLITUS, PERMANENT NEONATAL      INS ; KCNJ11 ; GCK ; ABCC8
#606232 CHROMOSOME 22Q13.3 DELETION SYNDROME;;TELOMERIC 22Q13 MONOSOMY SYNDROME;;PHELAN-MCDERMID SYNDROME      SHANK3
#606369 EPILEPTIC ENCEPHALOPATHY, LENNOX-GASTAUT TYPE;;ENCEPHALOPATHY OF CHILDHOOD      MAPK10
#606407 HYPOTONIA-CYSTINURIA SYNDROME;;CYSTINURIA WITH MITOCHONDRIAL DISEASE;;HOMOZYGOUS 2P16 DELETION SYNDROME, FORMERLYHOMOZYGOUS 2P21 DELETION SYNDROME, INCLUDED     
606519 PHACE ASSOCIATION;;PHACES ASSOCIATION     
LYMPHANGIOLEIOMYOMATOSIS      TSC1 ; TSC2
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6      GLUD1
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED      SLC2A1
#606812 FUMARASE DEFICIENCY;;FUMARIC ACIDURIA      FH
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL      GPR56
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4      TBP
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3      SLC25A19
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI      SCN1A
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS      ROBO3
#607330 LATHOSTEROLOSIS;;STEROL C5-DESATURASE DEFICIENCY;;SC5D DEFICIENCY      SC5D
FOCAL CORTICAL DYSPLASIA OF TAYLOR      TSC1
AUTISM, SUSCEPTIBILITY TO, 8     
#607426 COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1;;COQ10 DEFICIENCY, PRIMARY, 1;;UBIQUINONE DEFICIENCY 1;;COENZYME Q DEFICIENCY 1;;COQ DEFICIENCY 1      COQ2
LISSENCEPHALY 1; LIS1      PAFAH1B1
#607459 SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO;;SENSORY ATAXIC NEUROPATHY WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMALRECESSIVESPINOCEREBELLAR ATAXIA WITH EPILEPSY, INCLUDED; SCAE, INCLUDED      POLG
BASAL GANGLIA DISEASE, BIOTIN-RESPONSIVE      SLC19A3
GRISCELLI SYNDROME, TYPE 2      RAB27A
NIEMANN-PICK DISEASE, TYPE C2      NPC2
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING     
EPILEPSY, JUVENILE ABSENCE     
EPILEPSY, CHILDHOOD ABSENCE, 2     
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED     
#607745 SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 3; BFIC3;;SEIZURES, BENIGN FAMILIAL NEONATAL-INFANTILE; BFNIS      SCN2A
ALZHEIMER DISEASE 3      PSEN1
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A      LAMA2
#607872 CHROMOSOME 1P36 DELETION SYNDROME;;MONOSOMY 1P36 SYNDROME     
%607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME      FCMTE2
ALG2-CDG SYNDROME      ALG2
#607932 MICROPHTHALMIA, SYNDROMIC 6; MCOPS6;;MICROPHTHALMIA AND PITUITARY ANOMALIES;;MICROPHTHALMIA WITH BRAIN AND DIGIT DEVELOPMENTAL ANOMALIES;;ANOPHTHALMIA, CLINICAL, WITH MICROGNATHIA, MALFORMED EARS, DIGITALANOMALIES, AND ABNORMAL EXTERNAL GENITALIA      BMP4
GAUCHER DISEASE, PERINATAL LETHAL      GBA
%608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY      CLAM
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE      RANBP2
AUTISM, SUSCEPTIBILITY TO, 3     
#608093 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J;;CDG IJ; CDGIJ      DPAGT1
EPILEPSY, FAMILIAL TEMPORAL LOBE     
#608097 HETEROTOPIA, PERIVENTRICULAR, AUTOSOMAL RECESSIVE;;PERIVENTRICULAR NODULAR HETEROTOPIA 2; PVNH2;;PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE;ARPHM      ARFGEF2
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA ANDWRITER'S CRAMP     
%608154 LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORTSTATURE, AND SLENDER BONES     
EPILEPSY, BENIGN NEONATAL, 3     
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY     
#608363 CHROMOSOME 22Q11.2 DUPLICATION SYNDROME;;CHROMOSOME 22Q11.2 MICRODUPLICATION SYNDROME     
#608540 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K;;CDG IK; CDGIK      ALG1
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY      RPIA
AUTISM, SUSCEPTIBILITY TO, 4     
#608688 AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY;;ATIC DEFICIENCY;;AICA-RIBOSURIA DUE TO ATIC DEFICIENCY      ATIC
#608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD;;APLD, SUSCEPTIBILITY TO;;BARRAQUER-SIMONS SYNDROME;;LIPODYSTROPHY, CEPHALOTHORACIC TYPE;;LIPODYSTROPHY, PARTIAL, PROGRESSIVE     
WEGENER GRANULOMATOSIS     
#608716 MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5      ASPM
ALG9-CDG SYNDROME      ALG9
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY      PDP1
#608799 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE; CDG1E;;CDG IE; CDGIE      DPM1
PELIZAEUS-MERZBACHER-LIKE DISEASE, AUTOSOMAL RECESSIVE, 1      GJC2
608809 LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA;LACH     
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL      CPT2
#609029 EMANUEL SYNDROME;;SUPERNUMERARY DER(22)T(11;22) SYNDROME     
609037 MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY,AND SHORT STATURE     
CEROID LIPOFUSCINOSIS, NEURONAL, 9      CLN9
AMISH INFANTILE EPILEPSY SYNDROME      ST3GAL5
#609136 PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURGSYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH;;WAARDENBURG-SHAH SYNDROME, NEUROLOGIC VARIANT      SOX10
MPDU1-CDG SYNDROME      MPDU1
SCHINDLER DISEASE, TYPE I      NAGA
FEBRILE CONVULSIONS, FAMILIAL, 6      FEB6
FEBRILE CONVULSIONS, FAMILIAL, 5      FEB5
#609286 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 3; PEOA3;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 3      C10ORF2
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3      SLC25A22
CEREBRO-RENO-DIGITAL SYNDROME     
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK     
GENERALIZED EPILEPSY AND PAROXYSMAL DYSKINESIA      KCNMA1
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME      KIAA1279
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME      SNAP29
#609560 MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); MTDPS2;;MITOCHONDRIAL DNA DEPLETION MYOPATHY, TK2-RELATED      TK2
#609625 CHROMOSOME 10Q26 DELETION SYNDROME;;TERMINAL CHROMOSOME 10Q26 DELETION SYNDROME     
MIGRAINE, FAMILIAL HEMIPLEGIC, 3      SCN1A
#609734 PROOPIOMELANOCORTIN DEFICIENCY;;OBESITY, EARLY-ONSET, ADRENAL INSUFFICIENCY, AND RED HAIR      POMC
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4     
AMINOACYLASE 1 DEFICIENCY      ACY1
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5      INSR
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4      HADH
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT      CLN8
2-@METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY      ACADSB
#610015 GLUTAMINE DEFICIENCY, CONGENITAL;;GLUTAMINE SYNTHASE DEFICIENCY, CONGENITAL SYSTEMIC      GLUL
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7      SLC16A1
#610031 POLYMICROGYRIA, SYMMETRIC OR ASYMMETRIC; PMGYSA      TUBB2B
#610042 CORTICAL DYSPLASIA-FOCAL EPILEPSY SYNDROME;;CDFE SYNDROMEPITT-HOPKINS-LIKE SYNDROME 1, INCLUDED; PTHSL1, INCLUDED      CNTNAP2
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY      PNPO
#610125 MICROPHTHALMIA, SYNDROMIC 5; MCOPS5RETINAL DYSTROPHY, EARLY-ONSET, AND PITUITARY DYSFUNCTION, INCLUDED      OTX2
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED      CTSD
#610131 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 4; PEOA4;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 4      POLG2
OLIVOPONTOCEREBELLAR HYPOPLASIA, FETAL-ONSET     
#610217 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B;;NEURODEGENERATION WITH BRAIN IRON ACCUMULATION, PLA2G6-RELATED;;NEUROAXONAL DYSTROPHY, ATYPICALKARAK SYNDROME, INCLUDED      PLA2G6
#610253 KLEEFSTRA SYNDROME;;CHROMOSOME 9Q34.3 DELETION SYNDROME;;9Q- SYNDROME;;9Q SUBTELOMERIC DELETION SYNDROME      EHMT1
PACHYGYRIA, FRONTOTEMPORAL     
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY      PIGM
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 4      CHRNA2
#610377 MEVALONIC ACIDURIA; MEVA      MVK
#610443 KOOLEN-DE VRIES SYNDROME; KDVS;;CHROMOSOME 17Q21.31 DELETION SYNDROME;;MICRODELETION 17Q21.31 SYNDROME      KANSL1
#610505 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3;;ENCEPHALOMYOPATHY, RESPIRATORY FAILURE, AND LACTIC ACIDOSIS;;CONCENTRIC CARDIOMYOPATHY, HYPOTONIA, AND LACTIC ACIDOSIS      TSFM
#610532 LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5;;HYPOMYELINATION AND CONGENITAL CATARACT: HCC      FAM126A
#610536 MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA;;MANDIBULOFACIAL DYSOSTOSIS WITH MICROCEPHALY; MFDM;;GROWTH AND MENTAL RETARDATION, MANDIBULOFACIAL DYSOSTOSIS, MICROCEPHALY,AND CLEFT PALATE      EFTUD2
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY      PSAP
CHROMOSOME 16P13.3 DELETION SYNDROME     
NEUTROPENIA, SEVERE CONGENITAL, AUTOSOMAL RECESSIVE 3; SCN3      HAX1
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IM      DOLK
#610883 POTOCKI-LUPSKI SYNDROME; PTLS;;CHROMOSOME 17P11.2 DUPLICATION SYNDROME     
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7      MFSD8
#610954 PITT-HOPKINS SYNDROME; PTHS;;ENCEPHALOPATHY, SEVERE EPILEPTIC, WITH AUTONOMIC DYSFUNCTION;;MENTAL RETARDATION, SYNDROMAL, WITH INTERMITTENT HYPERVENTILATION      TCF4
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY      PSAT1
#611091 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5; MRT5      MRT5 ; NSUN2
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2     
#611182 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH; CDG2H;;CDG IIH; CDGIIH      COG8
#611225 SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18;;INTELLECTUAL DISABILITY, MOTOR DYSFUNCTION, AND JOINT CONTRACTURES;IDMDC      SPG18 ; ERLIN2
#611277 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3; GEFSP3;;GEFS+, TYPE 3; GEFS+3FEBRILE SEIZURES, FAMILIAL, 8, INCLUDED; FEB8, INCLUDED      GABRG2
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4     
#611523 PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6;;ENCEPHALOPATHY, FATAL INFANTILE, WITH MITOCHONDRIAL RESPIRATORY CHAINDEFECTS      RARS2
#611556 GLYCOGEN STORAGE DISEASE 0, MUSCLE;;GSD 0B; GSD0B;;MUSCLE GLYCOGEN STORAGE DISEASE 0;;MUSCLE GLYCOGEN SYNTHASE DEFICIENCY      GYS1
#611603 LISSENCEPHALY 3; LIS3      TUBA1A
%611630 EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3;;EPILEPSY, FAMILIAL MESIAL TEMPORAL LOBE; FMTLE     
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4     
FEBRILE CONVULSIONS, FAMILIAL, 9     
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC      EGF
#611719 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5      MRPS22
#611721 COMBINED SAPOSIN DEFICIENCY;;PROSAPOSIN DEFICIENCY; PSAPD;;COMBINED SAP DEFICIENCY      PSAP
#611726 EPILEPSY, PROGRESSIVE MYOCLONIC 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS;EPM3;;CEROID LIPOFUSCINOSIS, NEURONAL, 14; CLN14      KCTD7
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10      CEP290
%611816 TEMPLE-BARAITSER SYNDROME;;MENTAL RETARDATION, SEVERE, AND ABSENT NAILS OF HALLUX AND POLLEX     
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL     
16P11.2 MICRODELETION SYNDROME     
#611936 CHROMOSOME 3Q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3Q29 SYNDROME     
#611938 VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2;;VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC; VTSIP      CASQ2
611961 STEVENSON-CAREY SYNDROME     
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME     
#612015 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN; CDG1N;;CDG IN; CDGIN      RFT1
#612016 COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 9; SCAR9      ADCK3
#612073 MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH METHYLMALONICACIDURIA); MTDPS5;;MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM, WITHMETHYLMALONIC ACIDURIA, AUTOSOMAL RECESSIVE, SUCLA2-RELATED      SUCLA2
#612075 MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITHRENAL TUBULOPATHY); MTDPS8A;;MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC, WITH RENALTUBULOPATHY, AUTOSOMAL RECESSIVEMITOCHONDRIAL DNA DEPLETION SYNDROME 8B (MNGIE TYPE), INCLUDED; MTDP8B,INCLUDED;;MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME, RRM2B-RELATED,INCLUDED;;MNGIE, RRM2B-RELATED, INCLUDED      RRM2B
#612164 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4; EIEE4      STXBP1
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME      CTC1
#612233 LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4;;MITOCHONDRIAL HSP60 CHAPERONOPATHY;;MITCHAP60 DISEASE      HSPD1
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5      GABRB3
#612304 THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4;;PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE;;PROC DEFICIENCY, AUTOSOMAL RECESSIVE      PROC
#612313 CHROMOSOME 2Q32-Q33 DELETION SYNDROME     
#612319 SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE; SPG35;;FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION; FAHN;;LEUKODYSTROPHY, DYSMYELINATING, AND SPASTIC PARAPARESIS WITH OR WITHOUTDYSTONIA      FA2H
#612337 CHROMOSOME 1Q43-Q44 DELETION SYNDROME;;CHROMOSOME 1QTER DELETION SYNDROME     
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B      PRICKLE1
LEUKODYSTROPHY, HYPOMYELINATING, 6     
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC      GNAS
#612474 CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB     
#612475 CHROMOSOME 1Q21.1 DUPLICATION SYNDROME     
#612530 CHROMOSOME 1Q41-Q42 DELETION SYNDROME;;HOLOPROSENCEPHALY 10, INCLUDED; HPE10, INCLUDED     
#612582 CHROMOSOME 6PTER-P24 DELETION SYNDROME     
#612621 MENTAL RETARDATION, AUTOSOMAL DOMINANT 5; MRD5      SYNGAP1
#612656 EPISODIC ATAXIA, TYPE 6; EA6      SLC1A3
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY      SPR
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY      GAMT
#612780 SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, ANDELECTROLYTE IMBALANCE; SESAMES;;SESAME SYNDROME;;EPILEPSY, ATAXIA, SENSORINEURAL DEAFNESS, AND TUBULOPATHY;;EAST SYNDROME      KCNJ10
6Q25 MICRODELETION SYNDROME     
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD      FTO
612947 MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUALAPPEARANCE     
HYPOMYELINATION, GLOBAL CEREBRAL      SLC25A12
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY      RNASET2
%613001 ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL     
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED     
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY      FOLR1
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED      POMT2
#613159 NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1      XPNPEP3
BETA-UREIDOPROPIONASE DEFICIENCY      UPB1
GABA-TRANSAMINASE DEFICIENCY      ABAT
CHROMOSOME 5P13 DUPLICATION SYNDROME     
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA      TUBA8
#613192 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13      TRAPPC9
#613254 TUBEROUS SCLEROSIS 2; TSC2TSC2 ANGIOMYOLIPOMAS, RENAL, MODIFIER OF, INCLUDED      TSC2
613328 ROIFMAN-CHITAYAT SYNDROME;;COMBINED IMMUNODEFICIENCY, FACIAL DYSMORPHISM, OPTIC NERVE ATROPHY,SKELETAL ANOMALIES, AND DEVELOPMENTAL DELAY     
EPILEPSY, HOT WATER, 1; HWE1     
#613402 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 10; EIEE10;;MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY; MCSZ      PNKP
#613406 CHROMOSOME 15Q24 DELETION SYNDROMECHROMOSOME 15Q24 DUPLICATION SYNDROME, INCLUDED     
#613443 MENTAL RETARDATION, STEREOTYPIC MOVEMENTS, EPILEPSY, AND/OR CEREBRALMALFORMATIONS;;CHROMOSOME 5Q14.3 DELETION SYNDROME      MEF2C
#613454 RETT SYNDROME, CONGENITAL VARIANT      FOXG1
#613457 CHROMOSOME 14Q11-Q22 DELETION SYNDROME     
#613477 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5; EIEE5      SPTAN1
#613489 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J;;CDG IIJ; CDGIIJ      COG4
#613509 CHROMOSOME 4Q21 DELETION SYNDROME     
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3     
#613661 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P      ALG11
#613662 MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B;;MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME, POLG-RELATED;;MNGIE, POLG-RELATED      POLG
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY      MED17
#613675 CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB;;NEUROFIBROMATOSIS 1 MICRODELETION SYNDROME;;NF1 MICRODELETION SYNDROMENF1 MICRODUPLICATION SYNDROME, INCLUDED     
#613720 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7; EIEE7      KCNQ2
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11      SCN2A
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12      PLCB1
DISTAL 7Q11.23 MICRODELETION SYNDROME     
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS      JAM3
#613735 CHROMOSOME 1P32-P31 DELETION SYNDROME     
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY      AP4E1
#613759 INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, ANDCARDIOVASCULAR MALFORMATIONS;;FADD DEFICIENCY      FADD
#613792 CHROMOSOME 3PTER-P25 DELETION SYNDROME;;3P- SYNDROME     
#613811 PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D;;CEREBELLOCEREBRAL ATROPHY, PROGRESSIVE; PCCA;;CEREBELLO-CEREBRAL ATROPHY, PROGRESSIVE      SEPSECS
#613832 EPILEPSY, PROGRESSIVE MYOCLONIC 5; EPM5      PRICKLE2
#613839 MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY;;DHFR DEFICIENCY      DHFR
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED      SCN9A
#613925 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A      HEPACAM
#613971 EPILEPSY WITH NEURODEVELOPMENTAL DEFECTS; EPND      GRIN2A
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC 6; EPM6      GOSR2
#614019 LISSENCEPHALY 4; LIS4;;LISSENCEPHALY 4, WITH MICROCEPHALY      NDE1
#614039 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS; CDCBM      TUBB3
#614080 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1      PIGN
614098 KEPPEN-LUBINSKY SYNDROME; KPLBS     
#614115 CORTICAL MALFORMATIONS, OCCIPITAL; OCCM      LAMC3
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15      MAN1B1
#614212 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4     
#614219 ADAMS-OLIVER SYNDROME 2; AOS2      DOCK6
#614231 MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME; MEDS      IER3IP1
#614253 AMELOGENESIS IMPERFECTA AND GINGIVAL FIBROMATOSIS SYNDROME; AIGFS      FAM20A
%614261 MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME; MICCAP     
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9     
TETRASOMY 18P     
#614299 MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2; MMDS2      BOLA3
#614300 HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY      ADK
#614307 ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD;;AMACR DEFICIENCY      AMACR
%614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY     
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED      MEGF10
#614418 FEBRILE SEIZURES, FAMILIAL, 11; FEB11;;CONVULSIONS, FAMILIAL FEBRILE, 11      CPA6
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR      ELOVL4
#614458 THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHYTYPE); THMD5;;ENCEPHALOPATHY, EPISODIC, DUE TO THIAMINE PYROPHOSPHOKINASE DEFICIENCY      TPK1
#614462 PYRUVATE DEHYDROGENASE LIPOIC ACID SYNTHETASE DEFICIENCY; PDHLD      LIAS
#614482 CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND      SLC33A1
#614483 PORENCEPHALY 2; POREN2      COL4A2
#614487 SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5      AFG3L2
#614498 RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL      BRAT1
#614501 PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM;PMRED      SNIP1
614520 ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNELDEFICIENCY     
#614526 CHROMOSOME 17Q12 DUPLICATION SYNDROME     
#614527 CHROMOSOME 17Q12 DELETION SYNDROME     
#614558 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13; EIEE13      SCN8A
#614559 INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD      ACO2
%614561 LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS; LCC;;LABRUNE SYNDROME     
#614576 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L;;CDG IIL; CDGIIL      COG6
#614594 PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTICPLAQUES;;OLMSTED SYNDROME; OLMS      TRPV3
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6      COQ6
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3      PDSS2
16P11.2P12.2 MICRODUPLICATION SYNDROME     
614688 PONTINE TEGMENTAL CAP DYSPLASIA; PTCD     
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11      GRN
#614727 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK; CDG2K;;CDG IIK; CDGIIK      TMEM165
#614739 3-@METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKESYNDROME; MEGDEL      SERAC1
#614741 MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY; MPYCD      MPC1
#614749 HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2      PIGO
#614820 ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2      ATP1A3
#614831 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13      GRM1
#614833 POLYMICROGYRIA WITH SEIZURES; PMGYS      RTTN
#614845 NEPHRONOPHTHISIS 15; NPHP15      CEP164
#614847 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12     
#614851 SECKEL SYNDROME 7; SCKL7      NIN
#614859 PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3APEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 3, INCLUDED;CG3, INCLUDED      PEX12
#614862 PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER); PBD4APEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 4, INCLUDED;CG4, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 6, INCLUDED;CG6, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP C, INCLUDED;CGC, INCLUDED      PEX6
#614866 PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER); PBD5APEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 5, INCLUDED;CG5, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 10, INCLUDED;CG10, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP F, INCLUDED;CGF, INCLUDED      PEX2
#614870 PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6APEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 7, INCLUDED;CG7, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP B, INCLUDED;CGB, INCLUDED      PEX10
#614872 PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7APEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 8, INCLUDED;CG8, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP A, INCLUDED;CGA, INCLUDED      PEX26
#614876 PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8APEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 9, INCLUDED;CG9, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP D, INCLUDED;CGD, INCLUDED      PEX16
#614882 PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10APEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 12, INCLUDED;CG12, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP G, INCLUDED;CGG, INCLUDED      PEX3
#614883 PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11APEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 13, INCLUDED;CG13, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP H, INCLUDED;CGH, INCLUDED      PEX13
#614886 PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12APEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 14, INCLUDED;;CG14, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP J, INCLUDED;;CGJ, INCLUDED      PEX19
#614887 PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER); PBD13APEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP K, INCLUDED;CGK, INCLUDED      PEX14
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY      BCKDK
#614924 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12;;LEUKOENCEPHALOPATHY WITH THALAMUS AND BRAINSTEM INVOLVEMENT AND HIGHLACTATE; LTBL      EARS2
#614946 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14      FARS2
#614947 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15      MTFMT
#614959 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14      KCNT1
%614969 PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7     
#615005 EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5      KCNT1
#615006 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15      ST3GAL3
#615031 SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE; SPG49      TECPR2
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD      SLC25A1
#615191 LISSENCEPHALY 5; LIS5      LAMB1
48,XXYY SYNDROME     
ATAXIA-TELANGIECTASIA      ATM
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME      CEP57 ; BUB1B
SHORT STATURE - HEART DEFECT - CRANIOFACIAL ANOMALIES     
ARTHROGRYPOSIS - EPILEPTIC SEIZURES - MIGRATIONAL BRAIN DISORDER     
FACIAL ASYMMETRY - TEMPORAL SEIZURES     
INTELLECTUAL DEFICIT - ATHETOSIS- MICROPHTHALMIA     
CHRONIC MUCOCUTANEOUS CANDIDIASIS      IL17F ; IL17RA ; CLEC7A ; STAT1 ; CARD9 ; ICAM1
MICROCEPHALY - INTELLECTUAL DEFICIT - PHALANGEAL AND NEUROLOGICAL ANOMALIES     
ISOLATED CEREBELLAR HYPOPLASIA/AGENESIS     
RING CHROMOSOME 10     
COFFIN-SIRIS SYNDROME      ARID1B ; ARID1A ; SMARCB1 ; SMARCA4
COFS SYNDROME      ERCC1 ; ERCC2 ; ERCC5 ; ERCC6
COGAN SYNDROME     
MULTIPLE CARBOXYLASE DEFICIENCY     
CUTIS VERTICIS GYRATA - INTELLECTUAL DEFICIT     
DANDY WALKER - FACIAL HEMANGIOMA     
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY     
KNOBLOCH SYNDROME      COL18A1 ; ADAMTS18
DELETION 20P     
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME     
DENNIS-COHEN SYNDROME     
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS     
MOSAIC TRISOMY 14     
DISTAL TRISOMY 15Q     
CRANIOSYNOSTOSIS - HYDROCEPHALUS - CHIARI I MALFORMATION - RADIOULNAR SYNOSTOSIS     
DYSEQUILIBRIUM SYNDROME      CA8 ; VLDLR ; ATP8A2 ; WDR81
CENTRAL DIABETES INSIPIDUS     
EPIPHYSEAL DYSPLASIA - HEARING LOSS - DYSMORPHISM     
MUSCULAR DYSTROPHY - WHITE MATTER SPONGIOSIS     
SYSTEMIC CAPILLARY LEAK SYNDROME     
COCKAYNE SYNDROME     
EMBRYOFETOPATHY DUE TO ORAL ANTICOAGULANT THERAPY     
FRONTAL ENCEPHALOCELE     
BENIGN FAMILIAL NEONATAL SEIZURES      KCNQ2 ; KCNQ3
BILATERAL STRIOPALLIDODENTATE CALCINOSIS      SLC20A2 ; PDGFRB
CORNELIA DE LANGE SYNDROME      SMC1A ; HDAC8 ; SMC3 ; NIPBL ; RAD21
COWDEN SYNDROME      AKT1 ; SDHD ; PIK3CA ; SDHB ; KLLN ; PTEN
FOIX-CHAVANY-MARIE SYNDROME     
CRIGLER-NAJJAR SYNDROME     
X-LINKED INTELLECTUAL DEFICIT - EPILEPSY     
CUTIS LAXA     
GRIX-BLANKENSHIP-PETERSON SYNDROME     
HERNANDEZ-AGUIRRE NEGRETE SYNDROME     
NODULAR NEURONAL HETEROTOPIA     
HIRSCHSPRUNG DISEASE - GANGLIONEUROBLASTOMA     
NEURONAL CEROID LIPOFUSCINOSIS     
HOLOPROSENCEPHALY     
JOUBERT SYNDROME WITH OCULAR DEFECT      CEP41 ; AHI1 ; TMEM237 ; KIF7 ; TMEM231
JOUBERT SYNDROME WITH RENAL DEFECT      NPHP1 ; ATXN10 ; TMEM237 ; RPGRIP1L ; TCTN2
MATERNAL HYPERTHERMIA INDUCED BIRTH DEFECTS     
FAMILIAL ISOLATED HYPOPARATHYROIDISM     
PONTOCEREBELLAR HYPOPLASIA TYPE 1      EXOSC3 ; VRK1
2Q23.1 MICRODELETION SYNDROME      MBD5
JOUBERT SYNDROME WITH OCULORENAL DEFECT      ZNF423 ; TMEM216 ; TMEM237 ; CC2D2A ; CEP290 ; TMEM138
KABUKI SYNDROME      KMT2D ; KDM6A
KENNY-CAFFEY SYNDROME     
ANGIO-OSTEOHYPERTROPHIC SYNDROME     
1Q44 MICRODELETION SYNDROME     
CENTRAL BILATERAL MACROGYRIA     
MICRO SYNDROME      RAB3GAP2 ; RAB18 ; RAB3GAP1
2Q31.1 MICRODELETION SYNDROME     
8P11.2 DELETION SYNDROME      ANK1
MICROCEPHALY - SEIZURES - INTELLECTUAL DEFICIT - HEART DISEASE     
19P13.12 MICRODELETION SYNDROME     
MIDAS SYNDROMEMICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME      HCCS ; COX7B
MOYAMOYA DISEASE      RNF213 ; ACTA2
MYOPATHY - GROWTH DELAY - INTELLECTUAL DEFICIT - HYPOSPADIAS     
LINEAR VERRUCOUS NEVUS SYNDROME     
14Q12 MICRODELETION SYNDROME      FOXG1
15Q14 MICRODELETION SYNDROME     
16P13.11 MICRODELETION SYNDROME     
16Q24.3 MICRODELETION SYNDROME      ANKRD11
20P12.3 MICRODELETION SYNDROME      BMP2
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME     
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES 1 AND 3      RNU4ATAC
THANATOPHORIC DYSPLASIA     
INFANTILE AXONAL NEUROPATHY     
PORT-WINE NEVI - MEGA CISTERNA MAGNA - HYDROCEPHALUS     
OCULODENTODIGITAL DYSPLASIA      GJA1
OLIVOPONTOCEREBELLAR ATROPHY - DEAFNESS     
JOUBERT SYNDROME WITH OROFACIODIGITAL DEFECT      TCTN3 ; OFD1 ; TMEM216 ; KIF7
L1 SYNDROME     
10Q22.3Q23.3 MICRODELETION SYNDROME     
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS     
OSTEOGENESIS IMPERFECTA - RETINOPATHY - SEIZURES - INTELLECTUAL DEFICIT     
ALOPECIA-INTELLECTUAL DEFICIT SYNDROME     
PHAKOMATOSIS PIGMENTOVASCULARIS     
CONGENITAL RUBELLA SYNDROME     
PORENCEPHALY     
LEUKOCYTE ADHESION DEFICIENCY     
PSEUDO-ZELLWEGER SYNDROME     
BARAITSER-WINTER SYNDROME      ACTG1 ; ACTB
INTELLECTUAL DEFICIT - HYPOCUPREMIA - HYPOBETALIPOPROTEINEMIA     
INTELLECTUAL DEFICIT, X-LINKED - SHORT STATURE - OBESITY     
BENIGN FAMILIAL INFANTILE SEIZURES      KCNQ2 ; KCNQ3 ; PRRT2 ; SCN2A
ATYPICAL RETT SYNDROME      CDKL5 ; NTNG1 ; MECP2 ; FOXG1
SEVERE CANAVAN DISEASE      ASPA
INFANTILE SPASMS - BROAD THUMBS     
SPASTICITY - INTELLECTUAL DEFICIT - X-LINKED EPILEPSY      ARX
LUJO HEMORRHAGIC FEVER     
EBOLA HEMORRHAGIC FEVER     
RIFT VALLEY FEVER     
HEREDITARY HYPEREKPLEXIA      GPHN ; SLC6A5 ; GLRB ; GLRA1
DEAFNESS - ONYCHODYSTROPHY     
CENTRAL NERVOUS SYSTEM CALCIFICATION - DEAFNESS - TUBULAR ACIDOSIS - ANEMIA     
TRISOMY X     
TRISOMY 13     
VIRAL HEMORRHAGIC FEVER     
FAMILIAL MEDITERRANEAN FEVER      MEFV
WEAVER-WILLIAMS SYNDROME     
WHIPPLE DISEASE     
WOLFRAM SYNDROME      WFS1 ; CISD2
INFANTILE NEUROAXONAL DYSTROPHY      PLA2G6 ; FA2H
GALACTOSEMIA     
GM1 GANGLIOSIDOSIS     
GAUCHER DISEASE     
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY     
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS     
GRISCELLI DISEASE     
HYPOPHOSPHATASIA     
NEONATAL ADRENOLEUKODYSTROPHY      PEX19 ; PEX2 ; PEX12 ; PEX10 ; PEX14 ; PEX16 ; PEX5 ; PEX13 ; PEX1 ; PEX3 ; PEX6 ; PEX11B ; PEX26
JOUBERT SYNDROME      CEP41 ; TCTN1 ; TMEM67 ; ARL13B ; TMEM237 ; KIF7 ; INPP5E ; TMEM231 ; C5ORF42
LEIGH SYNDROME     
MICROLISSENCEPHALY - MICROMELIA     
AICARDI-GOUTIERES SYNDROME      ADAR ; RNASEH2A ; RNASEH2C ; TREX1 ; RNASEH2B ; SAMHD1
MAPLE SYRUP URINE DISEASE     
METACHROMATIC LEUKODYSTROPHY     
WYBURN-MASON SYNDROME     
22Q11.2 DELETION SYNDROME      HIRA ; GP1BB ; COMT ; TBX1 ; UFD1L ; ARVCF
MICROPHTHALMIA, LENZ TYPE      BCOR
MONILETHRIX      DSG4 ; KRT81 ; KRT86 ; KRT83
MUCOPOLYSACCHARIDOSIS TYPE 3     
MUSCLE EYE BRAIN DISEASE      FKRP ; POMGNT1 ; LARGE ; B3GALNT2 ; POMT1 ; POMT2
X-LINKED CENTRONUCLEAR MYOPATHY      MAMLD1 ; MTM1
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA     
NEUROFIBROMATOSIS TYPE 1      NF1
NIEMANN-PICK DISEASE TYPE C     
NEVUS COMEDONICUS SYNDROME     
LEBER CONGENITAL AMAUROSIS      LRAT ; CRX ; IMPDH1 ; NMNAT1 ; RD3 ; TULP1 ; RPGRIP1 ; CEP290 ; IQCB1 ; KCNJ13 ; LCA5 ; RDH12 ; AIPL1 ; GUCY2D ; RPE65 ; SPATA7 ; GDF6 ; CRB1
CUTIS VERTICIS GYRATA     
PELIZAEUS-MERZBACHER DISEASE     
FAMILIAL THROMBOCYTOSIS      JAK2 ; MPL ; THPO
HENOCH-SCHÖNLEIN PURPURA     
PYRUVATE DEHYDROGENASE DEFICIENCY     
POLYARTERITIS NODOSA     
RABIES     
INFANTILE REFSUM DISEASE      PEX19 ; PEX2 ; PEX12 ; PEX10 ; PEX14 ; PEX16 ; PEX5 ; PEX13 ; PEX1 ; PEX3 ; PEX6 ; PEX11B ; PEX26
MONOSOMY 9Q22.3     
RENDU-OSLER-WEBER DISEASE      ENG ; SMAD4 ; ACVRL1
RUBINSTEIN-TAYBI SYNDROME      EP300 ; CREBBP
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4      AMACR
CLASSICAL PHENYLKETONURIA      PAH
ADULT NEURONAL CEROID LIPOFUSCINOSIS     
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS     
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS     
SCLERODERMA     
TUBEROUS SCLEROSIS      TSC1 ; TSC2
MIXED CONNECTIVE TISSUE DISEASE     
SOTOS SYNDROME      NSD1 ; NFIX
ISOLATED SPINA BIFIDA     
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY     
SCRUB TYPHUS     
FREE SIALIC ACID STORAGE DISEASE     
INTELLECTUAL DEFICIT, X-LINKED, CANTAGREL TYPE      KIAA2022
INTELLECTUAL DEFICIT, X-LINKED - HYPOGAMMAGLOBULINEMIA - PROGRESSIVE NEUROLOGICAL DETERIORATION     
INTELLECTUAL DEFICIT, X-LINKED, PAI TYPE     
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE     
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE     
X-LINKED INTELLECTUAL DEFICIT - ATAXIA - APRAXIA     
CONGENITAL TOXOPLASMOSIS     
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY     
SIALIDOSIS TYPE 2     
WALKER-WARBURG SYNDROME      FKRP ; FKTN ; POMGNT1 ; LARGE ; B3GNT1 ; GTDC2 ; COL4A1 ; B3GALNT2 ; ISPD ; POMT1 ; TMEM5 ; POMT2
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2      ATP6V0A2 ; PYCR1
PRIMARY INTESTINAL LYMPHANGIECTASIA     
XERODERMA PIGMENTOSUM     
ZELLWEGER SYNDROME      PEX19 ; PEX2 ; PEX12 ; PEX10 ; PEX14 ; PEX16 ; PEX5 ; PEX13 ; PEX1 ; PEX3 ; PEX6 ; PEX11B ; PEX26
PFEIFFER SYNDROME TYPE 2      FGFR2
PFEIFFER SYNDROME TYPE 3      FGFR2
THANATOPHORIC DWARFISM TYPE II      FGFR3
X-LINKED INTELLECTUAL DEFICIT, GOLABI-ITO-HALL TYPE      PQBP1
SEVERE INTELLECTUAL DEFICIT - EPILEPSY - ANAL ANOMALIES - DISTAL PHALANGEAL HYPOPLASIA     
PITUITARY STALK INTERRUPTION SYNDROME      HESX1 ; LHX4
DISTAL MONOSOMY 19P13.3     
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION      EHMT1
48,XXXY SYNDROME     
49,XXXXY SYNDROME     
BROWN-VIALETTO-VAN LAERE SYNDROME      SLC52A3 ; SLC52A2
ADAMS-OLIVER SYNDROME      DOCK6 ; EOGT ; RBPJ ; ARHGAP31
LASSA FEVER     
NIPAH VIRUS DISEASE